HighCostDrugsDemo/data/drug_snomed_mapping_enriched.csv at 4375d220225967f3ed7064498ffc583f7034fff3

Files

T

Andrew Charlwood a31907aa1f feat: complete drug-aware indication matching and cleanup app_v2

- Remove app_v2.py (consolidated into pathways_app.py), fix __init__ import
- Add DimSearchTerm.csv, drug_indication_clusters.csv, drug_snomed_mapping_enriched.csv
  as reference data for SNOMED-based indication matching
- Add snomed_indication_mapping_query.sql (source for embedded cluster mapping)
- Update DESIGN_SYSTEM.md, RALPH_PROMPT.md, ralph.ps1, uv.lock

2026-02-06 00:33:29 +00:00

7.8 MiB

Raw Blame History

1	Drug	Indication	TA_ID	Search_Term	SNOMEDCode	SNOMEDDescription	CleanedDrugName	PrimaryDirectorate	AllDirectorates
2	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	156370009	Psoriatic arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
3	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	239802003	Juvenile psoriatic arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
4	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	239803008	Juvenile psoriatic arthritis with psoriasis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
5	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	239812005	Psoriatic arthritis with distal interphalangeal joint involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
6	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	430543001	Family history of psoriasis with psoriatic arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
7	ABATACEPT	Psoriatic arthritis after DMARDs	TA568	psoriatic arthritis	1036471000000109	Psoriatic Arthritis Impact of Disease 9 questionnaire score	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
8	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
9	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
10	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
11	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
12	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
13	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
14	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
15	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
16	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
17	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
18	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
19	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
20	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
21	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
22	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
23	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
24	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
25	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
26	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
27	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
28	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
29	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
30	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
31	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
32	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
33	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
34	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
35	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
36	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
37	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
38	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
39	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
40	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
41	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
42	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
43	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
44	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
45	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
46	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
47	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
48	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
49	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
50	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
51	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
52	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
53	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
54	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
55	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
56	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
57	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
58	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
59	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
60	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
61	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
62	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
63	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
64	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
65	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
66	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
67	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
68	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
69	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
70	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
71	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
72	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
73	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
74	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
75	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
76	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
77	ABATACEPT	Rheumatoid arthritis	TA141	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
78	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
79	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
80	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
81	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
82	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
83	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
84	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
85	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
86	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
87	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
88	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
89	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
90	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
91	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
92	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
93	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
94	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
95	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
96	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
97	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
98	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
99	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
100	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
101	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
102	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
103	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
104	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
105	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
106	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
107	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
108	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
109	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
110	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
111	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
112	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
113	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
114	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
115	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
116	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
117	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
118	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
119	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
120	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
121	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
122	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
123	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
124	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
125	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
126	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
127	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
128	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
129	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
130	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
131	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
132	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
133	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
134	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
135	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
136	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
137	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
138	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
139	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
140	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
141	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
142	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
143	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
144	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
145	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
146	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
147	ABATACEPT IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
148	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
149	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
150	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
151	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
152	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
153	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
154	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
155	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
156	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
157	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
158	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
159	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
160	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
161	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
162	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
163	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
164	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
165	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
166	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
167	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
168	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
169	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
170	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
171	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
172	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
173	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
174	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
175	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
176	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
177	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
178	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
179	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
180	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
181	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
182	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
183	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
184	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
185	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
186	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
187	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
188	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
189	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
190	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
191	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
192	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
193	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
194	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
195	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
196	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
197	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
198	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
199	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
200	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
201	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
202	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
203	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
204	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
205	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
206	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
207	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
208	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
209	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
210	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
211	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
212	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
213	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
214	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
215	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
216	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
217	ABATACEPT IN COMBINATION WITH METHOTREXATE	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
218	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
219	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
220	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
221	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
222	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
223	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
224	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
225	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
226	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
227	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
228	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
229	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
230	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
231	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
232	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
233	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
234	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
235	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
236	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
237	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
238	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
239	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
240	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
241	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
242	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
243	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
244	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
245	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
246	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
247	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
248	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
249	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
250	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
251	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
252	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
253	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
254	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
255	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
256	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
257	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
258	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
259	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
260	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
261	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
262	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
263	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
264	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
265	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
266	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
267	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
268	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
269	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
270	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
271	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
272	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
273	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
274	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
275	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
276	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
277	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
278	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
279	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
280	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
281	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
282	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
283	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
284	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
285	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
286	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
287	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Rheumatoid arthritis that has responded inadequately to one or more conventional disease-modifying anti-rheumatic drugs (DMARDs) only, including methotrexate	TA234	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
288	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
289	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
290	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
291	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
292	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
293	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
294	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
295	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
296	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
297	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
298	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
299	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
300	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
301	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
302	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
303	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
304	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
305	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
306	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
307	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
308	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
309	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
310	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
311	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
312	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
313	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
314	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
315	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
316	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
317	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
318	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
319	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
320	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
321	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
322	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
323	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
324	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
325	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
326	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
327	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
328	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
329	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
330	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
331	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
332	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
333	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
334	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
335	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
336	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
337	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
338	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
339	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
340	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
341	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
342	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
343	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
344	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
345	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
346	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
347	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
348	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
349	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
350	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
351	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
352	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
353	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
354	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
355	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
356	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
357	ABATACEPT IN COMBINATION WITH METHOTREXATE (2ND LINE)	Treatment of moderate to severe active rheumatoid arthritis after one or more conventional non-biological disease-modifying anti-rheumatic drugs including methotrexate	TA280	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
358	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
359	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
360	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
361	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
362	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
363	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
364	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
365	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
366	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
367	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
368	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
369	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
370	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
371	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
372	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
373	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
374	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
375	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
376	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
377	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
378	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
379	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
380	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
381	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
382	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
383	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
384	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
385	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
386	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
387	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
388	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
389	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
390	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
391	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
392	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
393	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
394	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
395	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
396	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
397	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
398	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
399	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
400	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
401	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
402	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
403	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
404	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
405	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
406	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
407	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
408	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
409	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
410	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
411	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
412	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
413	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
414	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
415	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
416	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
417	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
418	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
419	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
420	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
421	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
422	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
423	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
424	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
425	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
426	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
427	ABATACEPT WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
428	ABATECEPT	Treating juvenile idiopathic arthritis	TA373	juvenile idiopathic arthritis	410798004	Oligoarticular juvenile idiopathic arthritis	ABATECEPT	RHEUMATOLOGY	RHEUMATOLOGY\|PAEDIATRICS
429	ABATECEPT	Treating juvenile idiopathic arthritis	TA373	juvenile idiopathic arthritis	16044751000119106	Juvenile idiopathic arthritis, polyarthritis	ABATECEPT	RHEUMATOLOGY	RHEUMATOLOGY\|PAEDIATRICS
430	ABCIXIMAB	Acute coronary syndromes	TA047	acute coronary syndrome	837091000000100	H/O acute coronary syndrome	ABCIXIMAB	CARDIOLOGY	CARDIOLOGY
431	ABCIXIMAB (INTRAVENOUS)	Acute coronary syndromes	TA012	acute coronary syndrome	837091000000100	H/O acute coronary syndrome	ABCIXIMAB	CARDIOLOGY	CARDIOLOGY
432	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	134405005	Suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
433	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	160287004	FH: Breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
434	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	268547008	Screening for breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
435	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
436	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	429740004	Family history of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
437	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
438	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
439	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	706970001	TNBC - Triple-negative breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
440	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	94361000000105	Breast cancer detected by national screening programme	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
441	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
442	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
443	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
444	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
445	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	838351000000107	Education about risk of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
446	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	874291000000100	QCancer breast cancer risk	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
447	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
448	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
449	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
450	ABEMACICLIB	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA579	breast cancer	1035841000000108	Lymphoedema following breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
451	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	134405005	Suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
452	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	160287004	FH: Breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
453	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	268547008	Screening for breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
454	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
455	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	429740004	Family history of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
456	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
457	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
458	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	706970001	TNBC - Triple-negative breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
459	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	94361000000105	Breast cancer detected by national screening programme	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
460	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
461	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
462	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
463	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
464	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	838351000000107	Education about risk of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
465	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	874291000000100	QCancer breast cancer risk	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
466	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
467	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
468	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
469	ABEMACICLIB	Hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in combination with an aromatase inhibitor, as initial endocrine-based therapy. In pre- or perimenopausal women, the endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist	TA563	breast cancer	1035841000000108	Lymphoedema following breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
470	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	134405005	Suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
471	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	160287004	FH: Breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
472	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	hormone receptor	237521008	Hypothyroidism due to thyroid stimulating hormone receptor blocking antibody	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
473	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	268547008	Screening for breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
474	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
475	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	hormone receptor	417742002	Hormone receptor positive tumour	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
476	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	429740004	Family history of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
477	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
478	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
479	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	hormone receptor	438628005	Hormone receptor negative tumour	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
480	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	706970001	TNBC - Triple-negative breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
481	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	94361000000105	Breast cancer detected by national screening programme	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
482	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
483	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
484	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	hormone receptor	310871000000100	Tumour hormone receptor status	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
485	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
486	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
487	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	838351000000107	Education about risk of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
488	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	874291000000100	QCancer breast cancer risk	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
489	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
490	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
491	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
492	ABEMACICLIB WITH ENDOCRINE THERAPY	Adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence	TA810	breast cancer	1035841000000108	Lymphoedema following breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
493	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	134405005	Suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
494	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	160287004	FH: Breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
495	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	268547008	Screening for breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
496	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
497	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	429740004	Family history of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
498	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
499	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
500	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	706970001	TNBC - Triple-negative breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
501	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	94361000000105	Breast cancer detected by national screening programme	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
502	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
503	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
504	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
505	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
506	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	838351000000107	Education about risk of breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
507	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	874291000000100	QCancer breast cancer risk	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
508	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
509	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
510	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
511	ABEMACICLIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy	TA725	breast cancer	1035841000000108	Lymphoedema following breast cancer	ABEMACICLIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
512	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	315268008	Suspected prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
513	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	428262008	H/O: prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
514	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	698470001	Advice given about prostate cancer screening	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
515	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	712837004	Active surveillance of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
516	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	720007002	Prostate cancer care review	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
517	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	31011000119107	Prostate cancer screening declined	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
518	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	874211000000109	QCancer prostate cancer risk	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
519	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	878401000000104	No FH of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
520	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	1000561000000108	Urine PCA3 (prostate cancer antigen 3) targeted genetic test	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
521	ABIRATERONE	Newly diagnosed high-risk hormone-sensitive metastatic prostate cancer	TA721	prostate cancer	1034421000000103	Discharge from secondary care prostate cancer service	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
522	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	315268008	Suspected prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
523	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	428262008	H/O: prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
524	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	698470001	Advice given about prostate cancer screening	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
525	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	712837004	Active surveillance of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
526	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	720007002	Prostate cancer care review	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
527	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	31011000119107	Prostate cancer screening declined	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
528	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	874211000000109	QCancer prostate cancer risk	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
529	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	878401000000104	No FH of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
530	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	1000561000000108	Urine PCA3 (prostate cancer antigen 3) targeted genetic test	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
531	ABIRATERONE IN COMBINATION WITH PREDNISOLONE OR PREDNISONE (2ND LINE)	Treatment of castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen	TA259	prostate cancer	1034421000000103	Discharge from secondary care prostate cancer service	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
532	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	315268008	Suspected prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
533	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	428262008	H/O: prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
534	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	698470001	Advice given about prostate cancer screening	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
535	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	712837004	Active surveillance of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
536	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	720007002	Prostate cancer care review	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
537	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	31011000119107	Prostate cancer screening declined	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
538	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	874211000000109	QCancer prostate cancer risk	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
539	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	878401000000104	No FH of prostate cancer	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
540	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	1000561000000108	Urine PCA3 (prostate cancer antigen 3) targeted genetic test	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
541	ABIRATERONE IN COMBINATION WITH PREDNISONE OR PREDNISOLONE	Treating metastatic hormone-relapsed prostate cancer before chemotherapy	TA387	prostate cancer	1034421000000103	Discharge from secondary care prostate cancer service	ABIRATERONE	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|UROLOGY\|CLINICAL ONCOLOGY
542	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	238542007	Inverse pattern atopic dermatitis	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
543	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	238543002	Discoid atopic dermatitis	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
544	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	238544008	Erythrodermic atopic dermatitis	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
545	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	238545009	Follicular atopic dermatitis	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
546	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	238546005	Pruriginous atopic dermatitis	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
547	ABROCITINIB	Moderate to severe atopic dermatitis	TA814	atopic dermatitis	584621000000108	Atopic dermatitis NOS	ABROCITINIB	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
548	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	786855003	Monoclonal B-cell lymphocytosis chronic lymphocytic leukaemia-type	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
549	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	786855003	Monoclonal B-cell lymphocytosis chronic lymphocytic leukaemia-type	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
550	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863741000000108	Clinical stage A chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
551	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863741000000108	Clinical stage A chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
552	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863761000000109	Clinical stage B chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
553	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863761000000109	Clinical stage B chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
554	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863781000000100	Clinical stage C chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
555	ACALABRUTINIB	Chronic lymphocytic leukaemia	TA689	chronic lymphocytic leukaemia	863781000000100	Clinical stage C chronic lymphocytic leukaemia	ACALABRUTINIB	CLINICAL HAEMATOLOGY	CLINICAL HAEMATOLOGY
556	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	162930007	On examination - ankylosing spondylitis chest deformity	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
557	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	239805001	Juvenile ankylosing spondylitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
558	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	239810002	Ankylosing spondylitis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
559	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	239811003	Ankylosing spondylitis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
560	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	394990003	Family history: Ankylosing spondylitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
561	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	429712009	Bath Ankylosing Spondylitis Disease Activity Index	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
562	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	441562009	Bath Ankylosing Spondylitis Disease Activity Index score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
563	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	441680005	BASFI (Bath Ankylosing Spondylitis Functional Index) score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
564	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	ankylosing spondylitis	441930001	BASMI (Bath Ankylosing Spondylitis Metrology Index) score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
565	ADALIMUMAB	Ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	axial spondyloarthritis	723116002	Axial spondyloarthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
566	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	4927003	Acute anterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
567	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	11226001	Fuchs uveitis syndrome	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
568	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	43363007	Posterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
569	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	75614007	Panuveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
570	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	89114005	Infectious anterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
571	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	95707009	Phacotoxic uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
572	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	267619000	Non-infectious anterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
573	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	312922007	Uveitis related cystoid macular oedema	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
574	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	314029000	Tuberculous uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
575	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	314030005	Post-traumatic uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
576	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	314033007	Secondary open-angle glaucoma with uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
577	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	314493000	Postoperative uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
578	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	370506009	Keratouveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
579	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	398155003	Chronic anterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
580	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	410494003	Phacoantigenic uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
581	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	410692006	Anterior uveitis	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
582	ADALIMUMAB	Non-infectious uveitis	TA460	uveitis	342151000119100	Acute anterior uveitis of left eye	ADALIMUMAB	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY\|RHEUMATOLOGY
583	ADALIMUMAB	Plaque psoriasis	TA146	plaque psoriasis	200975007	Psoriasis vulgaris & (Chronic large plaque psoriasis)	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
584	ADALIMUMAB	Plaque psoriasis	TA146	plaque psoriasis	402307000	Chronic large plaque psoriasis	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
585	ADALIMUMAB	Plaque psoriasis	TA146	plaque psoriasis	402310007	Chronic stable plaque psoriasis	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
586	ADALIMUMAB	Plaque psoriasis in children and young people	TA455	plaque psoriasis	200975007	Psoriasis vulgaris & (Chronic large plaque psoriasis)	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
587	ADALIMUMAB	Plaque psoriasis in children and young people	TA455	plaque psoriasis	402307000	Chronic large plaque psoriasis	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
588	ADALIMUMAB	Plaque psoriasis in children and young people	TA455	plaque psoriasis	402310007	Chronic stable plaque psoriasis	ADALIMUMAB	DERMATOLOGY	DERMATOLOGY
589	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	156370009	Psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
590	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	156370009	Psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
591	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	239802003	Juvenile psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
592	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	239802003	Juvenile psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
593	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	239803008	Juvenile psoriatic arthritis with psoriasis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
594	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	239803008	Juvenile psoriatic arthritis with psoriasis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
595	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	239812005	Psoriatic arthritis with distal interphalangeal joint involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
596	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	239812005	Psoriatic arthritis with distal interphalangeal joint involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
597	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	430543001	Family history of psoriasis with psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
598	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	430543001	Family history of psoriasis with psoriatic arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
599	ADALIMUMAB	Psoriatic arthritis	TA125	psoriatic arthritis	1036471000000109	Psoriatic Arthritis Impact of Disease 9 questionnaire score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
600	ADALIMUMAB	Psoriatic arthritis	TA199	psoriatic arthritis	1036471000000109	Psoriatic Arthritis Impact of Disease 9 questionnaire score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|DERMATOLOGY
601	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
602	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
603	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
604	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
605	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
606	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
607	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
608	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
609	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
610	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
611	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
612	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
613	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
614	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
615	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
616	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
617	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
618	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
619	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
620	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
621	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
622	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
623	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
624	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
625	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
626	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
627	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
628	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
629	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
630	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
631	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
632	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
633	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
634	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
635	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
636	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
637	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
638	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
639	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
640	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
641	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
642	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
643	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
644	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
645	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
646	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
647	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
648	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
649	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
650	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
651	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
652	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
653	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
654	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
655	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
656	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
657	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
658	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
659	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
660	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
661	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
662	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
663	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
664	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
665	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
666	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
667	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
668	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
669	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
670	ADALIMUMAB	Rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
671	ADALIMUMAB	Severe active Crohn's disease (adults)	TA187	crohn's disease	196578009	Oral Crohn's disease	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|PAEDIATRIC GASTROENTEROLOGY\|COLORECTAL SURGERY
672	ADALIMUMAB	Severe active Crohn's disease (adults)	TA187	crohn's disease	196578009	Oral Crohn's disease	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|PAEDIATRIC GASTROENTEROLOGY\|COLORECTAL SURGERY
673	ADALIMUMAB	Severe active Crohn's disease (adults)	TA187	crohn's disease	273364009	Crohn's Disease Activity Index	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|PAEDIATRIC GASTROENTEROLOGY\|COLORECTAL SURGERY
674	ADALIMUMAB	Severe active Crohn's disease (adults)	TA187	crohn's disease	273364009	Crohn's Disease Activity Index	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|PAEDIATRIC GASTROENTEROLOGY\|COLORECTAL SURGERY
675	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	162930007	On examination - ankylosing spondylitis chest deformity	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
676	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	239805001	Juvenile ankylosing spondylitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
677	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	239810002	Ankylosing spondylitis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
678	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	239811003	Ankylosing spondylitis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
679	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	394990003	Family history: Ankylosing spondylitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
680	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	429712009	Bath Ankylosing Spondylitis Disease Activity Index	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
681	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	441562009	Bath Ankylosing Spondylitis Disease Activity Index score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
682	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	441680005	BASFI (Bath Ankylosing Spondylitis Functional Index) score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
683	ADALIMUMAB	Severe ankylosing spondylitis (adults)	TA143	ankylosing spondylitis	441930001	BASMI (Bath Ankylosing Spondylitis Metrology Index) score	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY
684	ADALIMUMAB	Treating juvenile idiopathic arthritis	TA373	juvenile idiopathic arthritis	410798004	Oligoarticular juvenile idiopathic arthritis	ABATECEPT	RHEUMATOLOGY	RHEUMATOLOGY\|PAEDIATRICS
685	ADALIMUMAB	Treating juvenile idiopathic arthritis	TA373	juvenile idiopathic arthritis	16044751000119106	Juvenile idiopathic arthritis, polyarthritis	ABATECEPT	RHEUMATOLOGY	RHEUMATOLOGY\|PAEDIATRICS
686	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	64766004	UC - ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
687	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	160383003	FH: Ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
688	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	201727001	Arthropathy in ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
689	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	275129008	Family history of ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
690	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	275549008	History of ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
691	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	414156000	Exacerbation of ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
692	ADALIMUMAB	Treatment of moderate to severe ulcerative colitis	TA262	ulcerative colitis	445243001	Left sided ulcerative colitis	ADALIMUMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
693	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	64766004	UC - ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
694	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	160383003	FH: Ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
695	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	201727001	Arthropathy in ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
696	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	275129008	Family history of ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
697	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	275549008	History of ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
698	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	414156000	Exacerbation of ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
699	ADALIMUMAB	moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	ulcerative colitis	445243001	Left sided ulcerative colitis	INFLIXIMAB	GASTROENTEROLOGY	GASTROENTEROLOGY\|COLORECTAL SURGERY
700	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
701	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
702	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
703	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
704	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
705	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
706	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
707	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
708	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
709	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
710	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
711	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
712	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
713	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
714	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
715	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
716	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
717	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
718	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
719	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
720	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
721	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
722	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
723	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
724	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
725	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
726	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
727	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
728	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
729	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
730	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
731	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
732	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
733	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
734	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
735	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
736	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
737	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
738	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
739	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
740	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
741	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
742	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
743	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
744	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
745	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
746	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
747	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
748	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
749	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
750	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
751	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
752	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
753	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
754	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
755	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
756	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
757	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
758	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
759	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
760	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
761	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
762	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
763	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
764	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
765	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
766	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
767	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
768	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
769	ADALIMUMAB (1ST LINE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
770	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
771	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
772	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
773	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
774	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
775	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
776	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
777	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
778	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
779	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
780	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
781	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
782	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
783	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
784	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
785	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
786	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
787	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
788	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
789	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
790	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
791	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
792	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
793	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
794	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
795	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
796	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
797	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
798	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
799	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
800	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
801	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
802	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
803	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
804	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
805	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
806	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
807	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
808	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
809	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
810	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
811	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
812	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
813	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
814	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
815	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
816	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
817	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
818	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
819	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
820	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
821	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
822	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
823	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
824	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
825	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
826	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
827	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
828	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
829	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
830	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
831	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
832	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
833	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
834	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
835	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
836	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
837	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
838	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
839	ADALIMUMAB (AFTER DMARD FAILURE)	Rheumatoid arthritis	TA130	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
840	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
841	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
842	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
843	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
844	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
845	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
846	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
847	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
848	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
849	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
850	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
851	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
852	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
853	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
854	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
855	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
856	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
857	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
858	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
859	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
860	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
861	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
862	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
863	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
864	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
865	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
866	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
867	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
868	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
869	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
870	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
871	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
872	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
873	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
874	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
875	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
876	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
877	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
878	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
879	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
880	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
881	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
882	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
883	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
884	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
885	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
886	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
887	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
888	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
889	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
890	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
891	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
892	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
893	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
894	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
895	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
896	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
897	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
898	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
899	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
900	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
901	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
902	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
903	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
904	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
905	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
906	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
907	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
908	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
909	ADALIMUMAB IN COMBINATION WITH METHOTREXATE (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
910	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
911	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
912	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
913	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
914	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
915	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
916	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
917	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
918	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
919	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
920	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
921	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
922	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
923	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
924	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
925	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
926	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
927	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
928	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
929	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
930	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
931	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
932	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
933	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
934	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
935	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
936	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
937	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
938	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
939	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
940	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
941	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
942	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
943	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
944	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
945	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
946	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
947	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
948	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
949	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
950	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
951	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
952	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
953	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
954	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
955	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
956	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
957	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
958	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
959	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
960	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
961	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
962	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
963	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
964	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
965	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
966	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
967	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
968	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
969	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
970	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
971	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
972	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
973	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
974	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
975	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
976	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
977	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
978	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
979	ADALIMUMAB MONOTHERAPY	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
980	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
981	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
982	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
983	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
984	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
985	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
986	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
987	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
988	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
989	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
990	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
991	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
992	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
993	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
994	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
995	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
996	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
997	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
998	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
999	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1000	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1001	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1002	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1003	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1004	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1005	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1006	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1007	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1008	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1009	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1010	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1011	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1012	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1013	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1014	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1015	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1016	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1017	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1018	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1019	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1020	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1021	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1022	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1023	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1024	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1025	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1026	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1027	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1028	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1029	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1030	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1031	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1032	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1033	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1034	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1035	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1036	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1037	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1038	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1039	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1040	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1041	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1042	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1043	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1044	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1045	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1046	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1047	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1048	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1049	ADALIMUMAB MONOTHERAPY (AFTER TNF FAILURE)	Rheumatoid arthritis	TA195	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ABATACEPT	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1050	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1961000	Chronic polyarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1051	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	28880005	Rheumatoid arthritis with carditis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1052	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	75822003	Acute juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1053	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	160413008	Family history: Rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1054	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	161567008	History of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1055	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193180002	Polyneuropathy in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1056	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	193250002	Myopathy due to rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1057	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201764007	Rheumatoid arthritis of cervical spine	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1058	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201766009	Rheumatoid arthritis of shoulder	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1059	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201767000	Rheumatoid arthritis of sternoclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1060	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201768005	Rheumatoid arthritis of acromioclavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1061	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201769002	Rheumatoid arthritis of elbow	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1062	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201771002	Rheumatoid arthritis of wrist	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1063	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201772009	Rheumatoid arthritis of metacarpophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1064	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201773004	Rheumatoid arthritis of proximal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1065	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201774005	Rheumatoid arthritis of distal interphalangeal joint of finger	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1066	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201775006	Rheumatoid arthritis of hip	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1067	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201776007	Rheumatoid arthritis of sacroiliac joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1068	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201777003	Rheumatoid arthritis of knee	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1069	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201778008	Rheumatoid arthritis of tibiofibular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1070	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201779000	Rheumatoid arthritis of ankle	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1071	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201780002	Rheumatoid arthritis of subtalar joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1072	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201781003	Rheumatoid arthritis of talonavicular joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1073	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201783000	Rheumatoid arthritis of 1st metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1074	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201784006	Rheumatoid arthritis of lesser metatarsophalangeal joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1075	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201785007	Rheumatoid arthritis of interphalangeal joint of toe	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1076	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201791009	Flare of rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1077	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201796004	Systemic onset juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1078	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	201799006	Monoarticular juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1079	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239791005	Seropositive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1080	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239792003	Seronegative rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1081	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239793008	Rheumatoid arthritis with organ / system involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1082	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	239795001	Rheumatoid arthritis with multisystem involvement	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1083	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	275902004	Rheumatoid arthritis monitoring	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1084	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287006005	Rheumatoid arthritis of multiple joints	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1085	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287007001	Rheumatoid arthritis of hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1086	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	287008006	Rheumatoid arthritis of ankle and/or foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1087	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	308143008	Seropositive erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1088	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	398640008	Rheumatoid arthritis with pneumoconiosis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1089	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	399923009	Rheumatoid arthritis with arteritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1090	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	400054000	Rheumatoid arthritis with vasculitis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1091	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410502007	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1092	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	410795001	Juvenile rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1093	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	429192004	Rheumatoid arthritis of foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1094	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	443728000	Disease activity score 28 joint in rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1095	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	735599007	Rheumatoid arthritis with erosion of joint	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1096	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1162303002	Seronegative erosive rheumatoid arthritis	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1097	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000000104	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation using preferred method of communication	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1098	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	143441000119108	Rheumatoid arthritis in remission	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1099	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805941000000105	Exception reporting - rheumatoid arthritis quality indicators	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1100	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805961000000106	Excepted from rheumatoid arthritis quality indicators - patient unsuitable	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1101	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	805981000000102	Excepted from rheumatoid arthritis quality indicators - informed dissent	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1102	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	847261000000104	Rheumatoid arthritis annual review	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1103	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882321000000105	Rheumatoid arthritis monitoring invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1104	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882401000000106	Rheumatoid arthritis monitoring invitation first letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1105	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882421000000102	Rheumatoid arthritis monitoring invitation second letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1106	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882441000000109	Rheumatoid arthritis monitoring invitation third letter	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1107	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882461000000105	Rheumatoid arthritis monitoring verbal invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1108	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	882481000000101	Rheumatoid arthritis monitoring telephone invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1109	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1010071000000108	Rheumatoid arthritis particle agglutination test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1110	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1016811000000108	Rheumatoid arthritis screening test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1111	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1029271000000101	Rheumatoid arthritis latex test	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1112	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1066991000000109	Rheumatoid arthritis monitoring invitation by SMS (short message service) text messaging	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1113	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067001000000103	Rheumatoid arthritis monitoring SMS (short message service) text message first invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1114	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067011000000101	Rheumatoid arthritis monitoring SMS (short message service) text message second invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1115	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1067021000000107	Rheumatoid arthritis monitoring SMS (short message service) text message third invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1116	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073781000119104	Rheumatoid arthritis of right foot	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1117	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1073791000119101	Rheumatoid arthritis of right hand	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1118	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1083081000000100	Rheumatoid arthritis monitoring invitation email	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1119	ADALIMUMAB WITH METHOTREXATE	Moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	rheumatoid arthritis	1110961000000108	QOF (Quality and Outcomes Framework) rheumatoid arthritis quality indicator-related care invitation	ADALIMUMAB	RHEUMATOLOGY	RHEUMATOLOGY\|CLINICAL IMMUNOLOGY\|GERIATRIC MEDICINE
1120	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	16584000	Administration of vaccine product containing only Hepatitis B virus antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1121	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	17627009	Hepatitis B e antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1122	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	22290004	Hepatitis B virus surface antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1123	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	47758006	Hepatitis B surface antigen level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1124	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	61977001	Chronic viral hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1125	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	76795007	Acute hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1126	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	81665004	Hepatitis B virus	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1127	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	82409003	Hepatitis B core antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1128	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	82645009	Hepatitis B virus surface antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1129	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	116800003	Hepatitis B Virus immune globulin administration	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1130	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	122450004	Hepatitis B virus antibody	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1131	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	161638000	Hepatitis B Occupational risk	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1132	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	165806002	Hepatitis B surface antigen positive	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1133	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	165807006	Hepatitis Be antigen present	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1134	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	165808001	Hepatitis B non-immune	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1135	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170370000	First hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1136	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170371001	Administration of second dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1137	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170372008	Third hepatitis B immunisation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1138	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170373003	Hepatitis B booster vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1139	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170374009	Fourth hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1140	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170375005	Administration of fifth dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1141	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170436000	Administration of third dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1142	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	170542003	Requires course of hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1143	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	171122006	Hepatitis B screening	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1144	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	171123001	Hepatitis B screening required	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1145	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	186626002	Acute hepatitis B with delta-agent (coinfection) without hepatic coma	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1146	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	192723002	Post hepatitis B vaccination encephalitis	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1147	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	235871004	Hepatitis B carrier	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1148	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	268504008	Anti-hepatitis B immunoglobulin given	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1149	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	271511000	Hepatitis B immune	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1150	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	278969009	Hepatitis B status	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1151	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	293110008	Adverse reaction to component of vaccine product containing Hepatitis B virus antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1152	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	294637001	Hepatitis B immunoglobulin allergy	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1153	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	294646007	Hepatitis B vaccine allergy	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1154	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	303233001	Antigen of Hepatitis B virus	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1155	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	313234004	Hepatitis B antibody present	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1156	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	406010001	Hepatitis B surface antigen not detected	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1157	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	408778004	Hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1158	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	416923003	Sixth hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1159	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	425569004	Hepatitis B immunization recommended	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1160	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	426519003	History of two doses hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1161	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	426980004	History of one dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1162	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	427390007	History of hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1163	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	429203008	History of three hepatitis B vaccinations	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1164	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	429721005	History of hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1165	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	698604002	Hepatitis B outbreak education	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1166	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	699037006	Hepatitis B vaccination contraindicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1167	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	707287001	Hepatitis B vaccination not indicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1168	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	736687002	Hepatitis B core antibody detected	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1169	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	736693005	Hepatitis B core antibody negative	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1170	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	736699009	Requires hepatitis B booster	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1171	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	770608009	Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1172	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	770616000	First diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunisation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1173	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	770617009	Second diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1174	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	770618004	Administration of third dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1175	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1162640003	Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1176	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	198041000000109	Hepatitis B vaccination refused	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1177	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	201591000000101	Advice on hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1178	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	202271000000108	Hepatitis B screening declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1179	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	204681000000104	Hepatitis B screening counselling	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1180	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	221021000000103	Hepatitis B treatment drugs Band 1	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1181	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	356121000000100	Hepatitis B screening positive	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1182	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	362851000000109	Hepatitis B screening negative	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1183	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	835791000000107	Hepatitis B vaccination invitation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1184	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	835811000000108	Hepatitis B vaccination invitation first letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1185	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	835831000000100	Hepatitis B vaccination invitation second letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1186	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	835851000000107	Hepatitis B vaccination invitation third letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1187	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	835871000000103	Hepatitis B vaccination verbal invitation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1188	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	839711000000101	Hepatitis B vaccination not offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1189	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	846421000000105	Hepatitis B screening not offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1190	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	865061000000108	First hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1191	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	865081000000104	Second hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1192	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	865101000000105	Third hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1193	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	865121000000101	Fourth hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1194	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	991971000000109	Hepatitis B immunity test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1195	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	991981000000106	Hepatitis B core antigen test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1196	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	991991000000108	Hepatitis B e antigen test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1197	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	995941000000101	Anti HBc (hepatitis B core) IgG level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1198	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1008441000000106	Hepatitis B deoxyribonucleic acid detection assay	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1199	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1008791000000106	HBsAg (hepatitis B surface antigen) antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1200	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1009271000000109	Hepatitis B screening test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1201	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1014201000000102	Hepatitis B surface antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1202	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1014211000000100	Hepatitis B surface antigen level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1203	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1014231000000108	Hepatitis B core antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1204	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1014241000000104	Hepatitis B e antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1205	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1028341000000105	Hepatitis B antigen screening	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1206	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1037211000000101	First hepatitis B vaccination given by other healthcare provider	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1207	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1037231000000109	Second hepatitis B vaccination given by other healthcare provider	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1208	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1060591000000103	Hepatitis B resolved	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1209	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1082431000000104	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1210	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1082441000000108	First diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1211	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1082451000000106	Second diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1212	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1082461000000109	Third diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1213	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1082521000000100	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1214	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1083421000000107	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination contraindicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1215	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1086431000000100	First diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1216	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1086441000000109	Second diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1217	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1086451000000107	Third diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1218	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1091701000000105	At risk of hepatitis B infection	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1219	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	1107691000000105	Hepatitis B screening offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1220	ADEFOVIR DIPIVOXIL	Hepatitis B (chronic)	TA096	hepatitis b	2427211000000109	Fourth diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1221	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	16584000	Administration of vaccine product containing only Hepatitis B virus antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1222	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	17627009	Hepatitis B e antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1223	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	22290004	Hepatitis B virus surface antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1224	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	47758006	Hepatitis B surface antigen level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1225	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	61977001	Chronic viral hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1226	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	76795007	Acute hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1227	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	81665004	Hepatitis B virus	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1228	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	82409003	Hepatitis B core antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1229	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	82645009	Hepatitis B virus surface antigen Ab	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1230	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	116800003	Hepatitis B Virus immune globulin administration	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1231	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	122450004	Hepatitis B virus antibody	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1232	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	161638000	Hepatitis B Occupational risk	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1233	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	165806002	Hepatitis B surface antigen positive	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1234	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	165807006	Hepatitis Be antigen present	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1235	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	165808001	Hepatitis B non-immune	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1236	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170370000	First hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1237	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170371001	Administration of second dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1238	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170372008	Third hepatitis B immunisation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1239	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170373003	Hepatitis B booster vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1240	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170374009	Fourth hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1241	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170375005	Administration of fifth dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1242	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170436000	Administration of third dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1243	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	170542003	Requires course of hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1244	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	171122006	Hepatitis B screening	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1245	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	171123001	Hepatitis B screening required	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1246	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	186626002	Acute hepatitis B with delta-agent (coinfection) without hepatic coma	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1247	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	192723002	Post hepatitis B vaccination encephalitis	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1248	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	235871004	Hepatitis B carrier	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1249	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	268504008	Anti-hepatitis B immunoglobulin given	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1250	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	271511000	Hepatitis B immune	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1251	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	278969009	Hepatitis B status	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1252	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	293110008	Adverse reaction to component of vaccine product containing Hepatitis B virus antigen	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1253	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	294637001	Hepatitis B immunoglobulin allergy	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1254	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	294646007	Hepatitis B vaccine allergy	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1255	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	303233001	Antigen of Hepatitis B virus	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1256	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	313234004	Hepatitis B antibody present	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1257	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	406010001	Hepatitis B surface antigen not detected	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1258	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	408778004	Hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1259	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	416923003	Sixth hepatitis B immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1260	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	425569004	Hepatitis B immunization recommended	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1261	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	426519003	History of two doses hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1262	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	426980004	History of one dose of hepatitis B vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1263	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	427390007	History of hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1264	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	429203008	History of three hepatitis B vaccinations	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1265	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	429721005	History of hepatitis B	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1266	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	698604002	Hepatitis B outbreak education	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1267	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	699037006	Hepatitis B vaccination contraindicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1268	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	707287001	Hepatitis B vaccination not indicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1269	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	736687002	Hepatitis B core antibody detected	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1270	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	736693005	Hepatitis B core antibody negative	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1271	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	736699009	Requires hepatitis B booster	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1272	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	770608009	Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1273	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	770616000	First diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunisation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1274	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	770617009	Second diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1275	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	770618004	Administration of third dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1276	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1162640003	Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1277	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	198041000000109	Hepatitis B vaccination refused	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1278	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	201591000000101	Advice on hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1279	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	202271000000108	Hepatitis B screening declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1280	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	204681000000104	Hepatitis B screening counselling	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1281	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	221021000000103	Hepatitis B treatment drugs Band 1	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1282	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	356121000000100	Hepatitis B screening positive	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1283	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	362851000000109	Hepatitis B screening negative	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1284	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	835791000000107	Hepatitis B vaccination invitation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1285	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	835811000000108	Hepatitis B vaccination invitation first letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1286	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	835831000000100	Hepatitis B vaccination invitation second letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1287	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	835851000000107	Hepatitis B vaccination invitation third letter	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1288	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	835871000000103	Hepatitis B vaccination verbal invitation	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1289	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	839711000000101	Hepatitis B vaccination not offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1290	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	846421000000105	Hepatitis B screening not offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1291	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	865061000000108	First hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1292	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	865081000000104	Second hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1293	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	865101000000105	Third hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1294	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	865121000000101	Fourth hepatitis B junior vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1295	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	991971000000109	Hepatitis B immunity test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1296	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	991981000000106	Hepatitis B core antigen test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1297	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	991991000000108	Hepatitis B e antigen test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1298	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	995941000000101	Anti HBc (hepatitis B core) IgG level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1299	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1008441000000106	Hepatitis B deoxyribonucleic acid detection assay	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1300	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1008791000000106	HBsAg (hepatitis B surface antigen) antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1301	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1009271000000109	Hepatitis B screening test	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1302	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1014201000000102	Hepatitis B surface antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1303	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1014211000000100	Hepatitis B surface antigen level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1304	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1014231000000108	Hepatitis B core antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1305	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1014241000000104	Hepatitis B e antibody level	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1306	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1028341000000105	Hepatitis B antigen screening	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1307	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1037211000000101	First hepatitis B vaccination given by other healthcare provider	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1308	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1037231000000109	Second hepatitis B vaccination given by other healthcare provider	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1309	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1060591000000103	Hepatitis B resolved	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1310	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1082431000000104	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1311	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1082441000000108	First diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1312	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1082451000000106	Second diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1313	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1082461000000109	Third diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1314	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1082521000000100	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1315	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1083421000000107	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination contraindicated	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1316	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1086431000000100	First diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1317	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1086441000000109	Second diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1318	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1086451000000107	Third diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1319	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1091701000000105	At risk of hepatitis B infection	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1320	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	1107691000000105	Hepatitis B screening offered	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1321	ADEFOVIR DIPIVOXIL IN COMBINATION WITH LAMIVUDINE	Hepatitis B (chronic)	TA096	hepatitis b	2427211000000109	Fourth diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	ADEFOVIR	GASTROENTEROLOGY	GASTROENTEROLOGY\|INFECTIOUS DISEASES
1322	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	162573006	Suspected lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1323	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	254637007	Non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1324	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	275981009	Lung cancer screening	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1325	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	429011007	Family history of lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1326	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	723301009	Squamous non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1327	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1259727001	Primary non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1328	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1259754003	Primary squamous NSCLC (non-small cell lung cancer)	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1329	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	276491000000101	Fast track referral for suspected lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1330	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	382681000000102	Seen in fast track suspected lung cancer clinic	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1331	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	848881000000108	QCancer lung cancer risk	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1332	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	877691000000107	No FH of lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1333	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1771781000000107	Did not attend lung cancer screening	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1334	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1792021000000109	PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian modified 2012) 6-year lung cancer risk calculator for smokers	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1335	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1792031000000106	Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers score	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1336	AFATINIB	Advanced squamous non-small-cell lung cancer after platinum-based chemotherapy	TA444	non-small-cell lung cancer	1792041000000102	Assessment using Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1337	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	162573006	Suspected lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1338	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	254637007	Non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1339	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	275981009	Lung cancer screening	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1340	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	429011007	Family history of lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1341	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	723301009	Squamous non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1342	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1259727001	Primary non-small cell lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1343	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1259754003	Primary squamous NSCLC (non-small cell lung cancer)	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1344	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	276491000000101	Fast track referral for suspected lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1345	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	382681000000102	Seen in fast track suspected lung cancer clinic	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1346	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	848881000000108	QCancer lung cancer risk	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1347	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	877691000000107	No FH of lung cancer	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1348	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1771781000000107	Did not attend lung cancer screening	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1349	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1792021000000109	PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian modified 2012) 6-year lung cancer risk calculator for smokers	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1350	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1792031000000106	Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers score	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1351	AFATINIB	Epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	non-small-cell lung cancer	1792041000000102	Assessment using Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers	AFATINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1352	AFLIBERCEPT	Choroidal neovascularisation	TA486	choroidal neovascularisation	733124000	Myopic choroidal neovascularisation	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1353	AFLIBERCEPT	Choroidal neovascularisation	TA486	choroidal neovascularisation	380621000000102	Subfoveal choroidal neovascularisation drugs Band 1	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1354	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	37231002	Macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1355	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	retinal vein occlusion	232038007	Central retinal vein occlusion with neovascularization	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1356	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	232039004	Central retinal vein occlusion with macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1357	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	retinal vein occlusion	232042005	Macular edema due to juvenile central retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1358	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	232045007	Macular oedema due to hemispheric retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1359	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	retinal vein occlusion	232045007	Macular oedema due to hemispheric retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1360	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	312911008	CSME - clinically significant macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1361	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	312912001	Macular oedema due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1362	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	312920004	Postoperative cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1363	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	312921000	Autosomal dominant cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1364	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	312922007	Uveitis related cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1365	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	769218003	Macular oedema of left eye due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1366	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	769221001	Clinically significant macular oedema of right eye due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1367	AFLIBERCEPT	Treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	macular oedema	895021000000102	Macular oedema drugs Band 1	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1368	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	37231002	Macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1369	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	retinal vein occlusion	232038007	Central retinal vein occlusion with neovascularization	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1370	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	232039004	Central retinal vein occlusion with macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1371	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	retinal vein occlusion	232042005	Macular edema due to juvenile central retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1372	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	232045007	Macular oedema due to hemispheric retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1373	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	retinal vein occlusion	232045007	Macular oedema due to hemispheric retinal vein occlusion	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1374	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	312911008	CSME - clinically significant macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1375	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	312912001	Macular oedema due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1376	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	312920004	Postoperative cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1377	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	312921000	Autosomal dominant cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1378	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	312922007	Uveitis related cystoid macular oedema	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1379	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	769218003	Macular oedema of left eye due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1380	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	769221001	Clinically significant macular oedema of right eye due to diabetes mellitus	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1381	AFLIBERCEPT SOLUTION FOR INJECTION	Visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	macular oedema	895021000000102	Macular oedema drugs Band 1	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1382	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	70099003	Familial juvenile macular degeneration syndrome	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1383	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	193384000	Senile macular degeneration	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1384	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	267718000	Age-related macular degeneration	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1385	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	312898002	Myopic macular degeneration	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1386	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	314427006	Drusen plus pigment change stage macular degeneration	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1387	AFLIBERCEPT SOLUTION FOR INJECTION	Wet age‑related macular degeneration	TA294	macular degeneration	1296526000	Disciform macular degeneration	AFLIBERCEPT	OPHTHALMOLOGY	OPHTHALMOLOGY\|MEDICAL OPHTHALMOLOGY
1388	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	191610000	Recurrent major depressive episodes, mild	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1389	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	191611001	Recurrent major depressive episodes, moderate	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1390	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	191613003	Recurrent major depressive episodes, severe, with psychosis	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1391	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	268621008	Recurrent major depressive episodes	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1392	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	755331000000108	Recurrent major depressive episodes, severe, with psychosis, psychosis in remission	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1393	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	764611000000100	Recurrent major depressive episodes, severe	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1394	AGOMELATINE	Major depressive episodes	TA231	major depressive episodes	764691000000109	Recurrent major depressive episodes, in partial remission	AGOMELATINE	MENTAL HEALTH	MENTAL HEALTH
1395	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	238542007	Inverse pattern atopic dermatitis	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1396	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	238543002	Discoid atopic dermatitis	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1397	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	238544008	Erythrodermic atopic dermatitis	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1398	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	238545009	Follicular atopic dermatitis	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1399	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	238546005	Pruriginous atopic dermatitis	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1400	ALCLOMETASONE DIPROPIONATE	Atopic dermatitis (eczema)	TA081	atopic dermatitis	584621000000108	Atopic dermatitis NOS	ALCLOMETASONE	DERMATOLOGY	DERMATOLOGY\|PAEDIATRICS\|CLINICAL IMMUNOLOGY
1401	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	162573006	Suspected lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1402	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	254637007	Non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1403	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	275981009	Lung cancer screening	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1404	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	429011007	Family history of lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1405	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	723301009	Squamous non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1406	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1259727001	Primary non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1407	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1259754003	Primary squamous NSCLC (non-small cell lung cancer)	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1408	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	276491000000101	Fast track referral for suspected lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1409	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	382681000000102	Seen in fast track suspected lung cancer clinic	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1410	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	848881000000108	QCancer lung cancer risk	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1411	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	877691000000107	No FH of lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1412	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1771781000000107	Did not attend lung cancer screening	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1413	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1792021000000109	PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian modified 2012) 6-year lung cancer risk calculator for smokers	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1414	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1792031000000106	Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers score	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1415	ALECTINIB	Non-small-cell lung cancer	TA536	non-small-cell lung cancer	1792041000000102	Assessment using Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1416	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	162573006	Suspected lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1417	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	254637007	Non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1418	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	275981009	Lung cancer screening	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1419	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	429011007	Family history of lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1420	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	723301009	Squamous non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1421	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1259727001	Primary non-small cell lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1422	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1259754003	Primary squamous NSCLC (non-small cell lung cancer)	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1423	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	276491000000101	Fast track referral for suspected lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1424	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	382681000000102	Seen in fast track suspected lung cancer clinic	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1425	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	848881000000108	QCancer lung cancer risk	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1426	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	877691000000107	No FH of lung cancer	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1427	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1771781000000107	Did not attend lung cancer screening	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1428	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1792021000000109	PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian modified 2012) 6-year lung cancer risk calculator for smokers	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1429	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1792031000000106	Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers score	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1430	ALECTINIB	Previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA438	non-small-cell lung cancer	1792041000000102	Assessment using Prostate, Lung, Colorectal, and Ovarian modified 2012 6-year lung cancer risk calculator for smokers	ALECTINIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|THORACIC MEDICINE\|CLINICAL ONCOLOGY
1431	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	24700007	Multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1432	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	160337009	Family history of multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1433	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	192926004	Brain stem multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1434	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	192927008	Multiple sclerosis of the spinal cord	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1435	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	192928003	Generalised multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1436	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	192929006	Exacerbation of multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1437	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	230372003	Acute relapsing multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1438	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	230373008	Chronic progressive multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1439	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	230374002	Remittent-progressive multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1440	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	425500002	Secondary progressive multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1441	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	426373005	Relapsing remitting multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1442	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	428700003	Primary progressive multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1443	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	438511000	Benign multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1444	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	698626001	Dementia associated with multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1445	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	700409000	Suspected multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1446	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	724778008	Progressive relapsing multiple sclerosis	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1447	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	166411000000100	Specialised services for patients with multiple sclerosis enhanced services administration	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1448	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	198491000000106	Multiple sclerosis review	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1449	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	205631000000104	Multiple sclerosis multidisciplinary review	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1450	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	367591000000101	Management of multiple sclerosis in early disease phase	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1451	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	367621000000103	Management of multiple sclerosis in stable disability phase	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1452	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	367651000000108	Management of multiple sclerosis in progressive disability phase	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1453	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	515931000000104	Multiple sclerosis review declined	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1454	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	758981000000100	Multiple sclerosis monitoring administration	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1455	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	759091000000105	Multiple sclerosis monitoring second letter	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1456	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	759131000000108	Multiple sclerosis monitoring telephone invitation	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1457	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	785851000000104	Referral to community multiple sclerosis team	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1458	ALEMTUZUMAB	Relapsing-remitting multiple sclerosis	TA312	multiple sclerosis	811881000000109	Multiple sclerosis care plan agreed	ALEMTUZUMAB	NEUROLOGY	NEUROLOGY\|REHABILITATION
1459	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	14651005	Drug-induced osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1460	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	18040001	Age-related osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1461	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	64859006	Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1462	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	102447009	Postmenopausal osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1463	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	160313009	Family history of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1464	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203429007	Idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1465	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203433000	Postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1466	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203435007	Localized osteoporosis - Lequesne	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1467	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203437004	Osteoporosis in endocrine disorders	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1468	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203438009	Osteoporosis of spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1469	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203444008	Osteoporotic fracture due to postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1470	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203445009	Osteoporosis of disuse with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1471	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203447001	Drug-induced osteoporosis with osteoporotic fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1472	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203448006	Idiopathic osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1473	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	203453001	Postmenopausal osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1474	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240155001	Adult idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1475	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240156000	Juvenile idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1476	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240157009	Secondary generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1477	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240158004	Regional migrating osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1478	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240159007	Transient osteoporosis of hip	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1479	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240160002	Transient osteoporosis of hip in pregnancy	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1480	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	240162005	Secondary localized osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1481	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	268028001	Localised disuse osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1482	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	276661002	Primary osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1483	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	281387004	Regional osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1484	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	300004007	Screening for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1485	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	309745002	Osteoporosis localized to spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1486	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	310251007	No family history: Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1487	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	313423004	At increased risk of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1488	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	390833005	Osteoporosis caused by corticosteroid	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1489	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391003008	Osteoporosis monitoring administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1490	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391004002	Attends osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1491	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391006000	Osteoporosis monitoring default	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1492	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391007009	Osteoporosis monitoring first letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1493	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391008004	Osteoporosis monitoring second letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1494	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391011003	Osteoporosis monitoring telephone invitation	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1495	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391012005	Osteoporosis monitoring deleted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1496	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391013000	Osteoporosis monitoring check done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1497	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391014006	Osteoporosis risk assessment done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1498	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391015007	Osteoporosis risk assessment declined	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1499	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391016008	Osteoporosis risk assessment defaulted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1500	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391017004	Osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1501	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391018009	Initial osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1502	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391019001	Follow-up osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1503	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391020007	Osteoporosis treatment started	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1504	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391021006	Osteoporosis treatment stopped	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1505	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391022004	Osteoporosis treatment changed	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1506	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391023009	Osteoporosis - no treatment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1507	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391024003	Osteoporosis - dietary advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1508	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391025002	Osteoporosis - dietary assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1509	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391026001	Osteoporosis - exercise advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1510	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391027005	Osteoporosis - falls prevention	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1511	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391028000	Osteoporosis - treatment response	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1512	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391033001	Refer to osteoporosis specialist	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1513	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391037000	Seen in osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1514	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391060008	Dual energy X-ray absorptiometry of bone of forearm result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1515	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391065003	Dual energy X-ray absorptiometry of calcaneum result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1516	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391070005	Dual energy X-ray absorptiometry of bone of hip joint region result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1517	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	391075000	Dual energy X-ray absorptiometry of bone of lumbar vertebra result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1518	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	394936006	Health education - osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1519	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	412717001	Referral to osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1520	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	440100002	Dual energy X-ray absorptiometry of neck of femur result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1521	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	473120007	History of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1522	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	739301006	Osteoporosis co-occurrent and due to multiple myeloma	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1523	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	763322002	Osteoporosis monitoring refused	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1524	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	278781000000105	Osteoporosis treatment not indicated	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1525	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	505141000000108	Osteoporosis enhanced services administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1526	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	505171000000102	Bone sparing drug treatment offered for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1527	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	711141000000109	Osteoporosis medication prophylaxis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1528	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	711341000000106	Osteoporosis resolved	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1529	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	753711000000102	Exception reporting - osteoporosis quality indicators	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1530	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	753791000000106	Excepted from osteoporosis quality indicators - patient unsuitable	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1531	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	753831000000104	Excepted from osteoporosis quality indicators - informed dissent	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1532	ALENDRONATE	Fragility fractures in postmenopausal women with osteoporosis (secondary prevention)	TA161	osteoporosis	965871000000101	Osteoporosis medication compliance review	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1533	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	14651005	Drug-induced osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1534	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	18040001	Age-related osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1535	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	64859006	Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1536	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	102447009	Postmenopausal osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1537	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	160313009	Family history of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1538	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203429007	Idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1539	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203433000	Postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1540	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203435007	Localized osteoporosis - Lequesne	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1541	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203437004	Osteoporosis in endocrine disorders	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1542	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203438009	Osteoporosis of spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1543	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203444008	Osteoporotic fracture due to postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1544	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203445009	Osteoporosis of disuse with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1545	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203447001	Drug-induced osteoporosis with osteoporotic fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1546	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203448006	Idiopathic osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1547	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	203453001	Postmenopausal osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1548	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240155001	Adult idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1549	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240156000	Juvenile idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1550	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240157009	Secondary generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1551	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240158004	Regional migrating osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1552	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240159007	Transient osteoporosis of hip	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1553	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240160002	Transient osteoporosis of hip in pregnancy	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1554	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	240162005	Secondary localized osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1555	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	268028001	Localised disuse osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1556	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	276661002	Primary osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1557	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	281387004	Regional osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1558	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	300004007	Screening for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1559	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	309745002	Osteoporosis localized to spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1560	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	310251007	No family history: Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1561	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	313423004	At increased risk of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1562	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	390833005	Osteoporosis caused by corticosteroid	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1563	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391003008	Osteoporosis monitoring administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1564	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391004002	Attends osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1565	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391006000	Osteoporosis monitoring default	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1566	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391007009	Osteoporosis monitoring first letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1567	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391008004	Osteoporosis monitoring second letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1568	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391011003	Osteoporosis monitoring telephone invitation	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1569	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391012005	Osteoporosis monitoring deleted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1570	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391013000	Osteoporosis monitoring check done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1571	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391014006	Osteoporosis risk assessment done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1572	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391015007	Osteoporosis risk assessment declined	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1573	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391016008	Osteoporosis risk assessment defaulted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1574	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391017004	Osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1575	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391018009	Initial osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1576	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391019001	Follow-up osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1577	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391020007	Osteoporosis treatment started	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1578	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391021006	Osteoporosis treatment stopped	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1579	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391022004	Osteoporosis treatment changed	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1580	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391023009	Osteoporosis - no treatment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1581	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391024003	Osteoporosis - dietary advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1582	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391025002	Osteoporosis - dietary assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1583	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391026001	Osteoporosis - exercise advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1584	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391027005	Osteoporosis - falls prevention	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1585	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391028000	Osteoporosis - treatment response	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1586	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391033001	Refer to osteoporosis specialist	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1587	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391037000	Seen in osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1588	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391060008	Dual energy X-ray absorptiometry of bone of forearm result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1589	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391065003	Dual energy X-ray absorptiometry of calcaneum result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1590	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391070005	Dual energy X-ray absorptiometry of bone of hip joint region result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1591	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	391075000	Dual energy X-ray absorptiometry of bone of lumbar vertebra result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1592	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	394936006	Health education - osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1593	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	412717001	Referral to osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1594	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	440100002	Dual energy X-ray absorptiometry of neck of femur result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1595	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	473120007	History of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1596	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	739301006	Osteoporosis co-occurrent and due to multiple myeloma	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1597	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	763322002	Osteoporosis monitoring refused	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1598	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	278781000000105	Osteoporosis treatment not indicated	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1599	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	505141000000108	Osteoporosis enhanced services administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1600	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	505171000000102	Bone sparing drug treatment offered for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1601	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	711141000000109	Osteoporosis medication prophylaxis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1602	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	711341000000106	Osteoporosis resolved	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1603	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	753711000000102	Exception reporting - osteoporosis quality indicators	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1604	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	753791000000106	Excepted from osteoporosis quality indicators - patient unsuitable	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1605	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	753831000000104	Excepted from osteoporosis quality indicators - informed dissent	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1606	ALENDRONATE	Osteoporosis - secondary prevention	TA087	osteoporosis	965871000000101	Osteoporosis medication compliance review	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1607	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	14651005	Drug-induced osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1608	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	18040001	Age-related osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1609	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	64859006	Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1610	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	102447009	Postmenopausal osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1611	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	160313009	Family history of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1612	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203429007	Idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1613	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203433000	Postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1614	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203435007	Localized osteoporosis - Lequesne	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1615	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203437004	Osteoporosis in endocrine disorders	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1616	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203438009	Osteoporosis of spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1617	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203444008	Osteoporotic fracture due to postoophorectomy osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1618	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203445009	Osteoporosis of disuse with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1619	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203447001	Drug-induced osteoporosis with osteoporotic fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1620	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203448006	Idiopathic osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1621	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	203453001	Postmenopausal osteoporosis with pathological fracture	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1622	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240155001	Adult idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1623	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240156000	Juvenile idiopathic generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1624	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240157009	Secondary generalised osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1625	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240158004	Regional migrating osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1626	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240159007	Transient osteoporosis of hip	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1627	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240160002	Transient osteoporosis of hip in pregnancy	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1628	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	240162005	Secondary localized osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1629	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	268028001	Localised disuse osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1630	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	276661002	Primary osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1631	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	281387004	Regional osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1632	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	300004007	Screening for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1633	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	309745002	Osteoporosis localized to spine	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1634	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	310251007	No family history: Osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1635	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	313423004	At increased risk of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1636	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	390833005	Osteoporosis caused by corticosteroid	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1637	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391003008	Osteoporosis monitoring administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1638	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391004002	Attends osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1639	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391006000	Osteoporosis monitoring default	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1640	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391007009	Osteoporosis monitoring first letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1641	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391008004	Osteoporosis monitoring second letter	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1642	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391011003	Osteoporosis monitoring telephone invitation	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1643	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391012005	Osteoporosis monitoring deleted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1644	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391013000	Osteoporosis monitoring check done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1645	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391014006	Osteoporosis risk assessment done	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1646	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391015007	Osteoporosis risk assessment declined	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1647	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391016008	Osteoporosis risk assessment defaulted	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1648	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391017004	Osteoporosis monitoring	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1649	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391018009	Initial osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1650	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391019001	Follow-up osteoporosis assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1651	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391020007	Osteoporosis treatment started	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1652	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391021006	Osteoporosis treatment stopped	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1653	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391022004	Osteoporosis treatment changed	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1654	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391023009	Osteoporosis - no treatment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1655	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391024003	Osteoporosis - dietary advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1656	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391025002	Osteoporosis - dietary assessment	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1657	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391026001	Osteoporosis - exercise advice	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1658	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391027005	Osteoporosis - falls prevention	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1659	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391028000	Osteoporosis - treatment response	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1660	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391033001	Refer to osteoporosis specialist	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1661	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391037000	Seen in osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1662	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391060008	Dual energy X-ray absorptiometry of bone of forearm result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1663	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391065003	Dual energy X-ray absorptiometry of calcaneum result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1664	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391070005	Dual energy X-ray absorptiometry of bone of hip joint region result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1665	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	391075000	Dual energy X-ray absorptiometry of bone of lumbar vertebra result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1666	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	394936006	Health education - osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1667	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	412717001	Referral to osteoporosis clinic	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1668	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	440100002	Dual energy X-ray absorptiometry of neck of femur result osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1669	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	473120007	History of osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1670	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	739301006	Osteoporosis co-occurrent and due to multiple myeloma	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1671	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	763322002	Osteoporosis monitoring refused	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1672	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	278781000000105	Osteoporosis treatment not indicated	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1673	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	505141000000108	Osteoporosis enhanced services administration	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1674	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	505171000000102	Bone sparing drug treatment offered for osteoporosis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1675	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	711141000000109	Osteoporosis medication prophylaxis	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1676	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	711341000000106	Osteoporosis resolved	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1677	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	753711000000102	Exception reporting - osteoporosis quality indicators	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1678	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	753791000000106	Excepted from osteoporosis quality indicators - patient unsuitable	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1679	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	753831000000104	Excepted from osteoporosis quality indicators - informed dissent	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1680	ALENDRONATE	Primary prevention of fragility fractures in postmenopausal women with osteoporosis	TA160	osteoporosis	965871000000101	Osteoporosis medication compliance review	ALENDRONATE	RHEUMATOLOGY	RHEUMATOLOGY\|ENDOCRINOLOGY\|GERIATRIC MEDICINE
1681	ALIROCUMAB	Treating primary hypercholesterolaemia and mixed dyslipidaemia	TA393	primary hypercholesterolaemia	238076009	Primary hypercholesterolaemia	ALIROCUMAB	CARDIOLOGY	CARDIOLOGY\|ENDOCRINOLOGY\|CHEMICAL PATHOLOGY
1682	ALITRETINOIN	Severe chronic hand eczema	TA177	hand eczema	238556009	Psoriasiform hand eczema	ALITRETINOIN	DERMATOLOGY	DERMATOLOGY
1683	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	134405005	Suspected breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1684	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	160287004	FH: Breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1685	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	268547008	Screening for breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1686	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1687	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	429740004	Family history of breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1688	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1689	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1690	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	706970001	TNBC - Triple-negative breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1691	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	94361000000105	Breast cancer detected by national screening programme	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1692	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1693	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1694	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1695	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1696	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	838351000000107	Education about risk of breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1697	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	874291000000100	QCancer breast cancer risk	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1698	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1699	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1700	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1701	ALPELISIB WITH FULVESTRANT	Hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer	TA816	breast cancer	1035841000000108	Lymphoedema following breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1702	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	134405005	Suspected breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1703	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	160287004	FH: Breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1704	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	268547008	Screening for breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1705	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	405823003	Breast cancer 1, early onset gene mutation carrier detection test	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1706	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	429740004	Family history of breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1707	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	431330007	Family history of breast cancer 1 gene mutation	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1708	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	431331006	Family history of breast cancer 2 gene mutation	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1709	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	706970001	TNBC - Triple-negative breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1710	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	94361000000105	Breast cancer detected by national screening programme	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1711	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	143691000119102	Family history of breast cancer gene mutation in first degree relative	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1712	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	276341000000100	Fast track referral for suspected breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1713	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	382431000000103	Seen in fast track suspected breast cancer clinic	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1714	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	836761000000105	National Cancer Institute breast cancer risk assessment tool	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1715	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	838351000000107	Education about risk of breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1716	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	874291000000100	QCancer breast cancer risk	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1717	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	895171000000104	Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1718	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	919701000000100	No FH of breast cancer meeting NICE CG164 referral criteria	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1719	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	1034381000000107	Discharge from secondary care breast cancer service	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1720	ALPELISIB WITH FULVESTRANT	Hormone-receptor positive, HER2-negative, PIK3CA-positive advanced breast cancer	TA652	breast cancer	1035841000000108	Lymphoedema following breast cancer	ALPELISIB	MEDICAL ONCOLOGY	MEDICAL ONCOLOGY\|BREAST SURGERY\|CLINICAL ONCOLOGY
1721	ALTEPLASE	Ischaemic stroke (acute)	TA122	ischaemic stroke	422504002	Ischaemic stroke	ALTEPLASE	STROKE MEDICINE	STROKE MEDICINE\|NEUROLOGY
1722	ALTEPLASE	Ischaemic stroke (acute)	TA264	ischaemic stroke	422504002	Ischaemic stroke	ALTEPLASE	STROKE MEDICINE	STROKE MEDICINE\|NEUROLOGY
1723	ALTEPLASE	Ischaemic stroke (acute)	TA122	ischaemic stroke	788880006	Cerebral ischaemic stroke due to dissection of artery	ALTEPLASE	STROKE MEDICINE	STROKE MEDICINE\|NEUROLOGY
1724	ALTEPLASE	Ischaemic stroke (acute)	TA264	ischaemic stroke	788880006	Cerebral ischaemic stroke due to dissection of artery	ALTEPLASE	STROKE MEDICINE	STROKE MEDICINE\|NEUROLOGY
1725	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	1755008	Healed myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1726	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	15990001	Acute myocardial infarction of posterolateral wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1727	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	22298006	MI - myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1728	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	41380003	Radioisotope scan for myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1729	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	52035003	Acute anteroapical myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1730	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	54329005	Acute anterior myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1731	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	57054005	Acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1732	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	58612006	Acute myocardial infarction of lateral wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1733	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	62695002	Acute anteroseptal myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1734	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	65547006	Acute inferolateral myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1735	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	66189004	Postmyocardial infarction syndrome	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1736	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	70211005	Acute anterolateral myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1737	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	73795002	Acute myocardial infarction of diaphragmatic wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1738	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	76593002	Acute myocardial infarction of inferoposterior wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1739	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	79009004	Acute myocardial infarction of septum	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1740	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	129574000	Postoperative myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1741	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	160361002	FH: ischemic heart disease (& [myocardial infarction] or [coronary thrombosis])	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1742	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	164866006	Electrocardiogram: no myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1743	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	164867002	Electrocardiographic old myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1744	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194809007	Acute myocardial infarction of atrium	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1745	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194821006	Aborted myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1746	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194856005	Subsequent myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1747	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194857001	Subsequent myocardial infarction of anterior wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1748	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194858006	Subsequent myocardial infarction of inferior wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1749	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194862000	Hemopericardium due to and following acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1750	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194863005	Atrial septal defect due to and following acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1751	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194865003	Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1752	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	194868001	Thrombosis of atrium, auricular appendage, and ventricle due to and following acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1753	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233838001	Acute posterior myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1754	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233839009	Old anterior myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1755	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233840006	Old inferior myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1756	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233841005	Old lateral myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1757	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233842003	Old posterior myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1758	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233843008	Silent myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1759	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233847009	Cardiac rupture due to and following acute myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1760	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	233885007	Pericarditis following myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1761	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	266288001	Myocardial infarction (& [acute]) or coronary thrombosis	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1762	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	266897007	Family history of myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1763	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	275122004	Family history: Myocardial infarction at less than 60	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1764	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	275123009	Family history: Myocardial infarction at greater than 60	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1765	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	304914007	Acute Q wave myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1766	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	308065005	History of myocardial infarction in last year	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1767	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	311793000	Postoperative transmural myocardial infarction of inferior wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1768	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	311796008	Postoperative subendocardial myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1769	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	314207007	Non-Q wave myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1770	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	315619001	Family history of myocardial infarction in male relative of first degree, age known	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1771	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	315620007	Family history of myocardial infarction in male relative of first degree, age unknown	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1772	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	315621006	Family history of myocardial infarction in female relative of first degree, age known	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1773	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	315622004	Family history of myocardial infarction in female relative of first degree, age unknown	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1774	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	394710008	First myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1775	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	399211009	Previous myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1776	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	401303003	STEMI - ST elevation myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1777	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	401314000	Acute non-ST segment elevation myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1778	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	698593009	History of non-ST segment elevation myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1779	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	703164000	Acute anterior ST segment elevation myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1780	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	703213009	Acute STEMI (ST elevation myocardial infarction) of inferior wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1781	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	827164008	Delayed postmyocardial infarction syndrome	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1782	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	879955009	MINOCA - myocardial infarction with non-obstructive coronary artery	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1783	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	515711000000105	Family history of myocardial infarction in second degree relative less than 50 years	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1784	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	515741000000106	Family history of myocardial infarction in first degree relative less than 60 years	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1785	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	715971000000103	Excepted from myocardial infarction quality indicators - informed dissent	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1786	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	715981000000101	Excepted from myocardial infarction quality indicators - patient unsuitable	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1787	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	717541000000106	Exception reporting - myocardial infarction quality indicators	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1788	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	883961000000109	Thrombolysis In Myocardial Infarction risk score for unstable angina or non-ST-segment-elevation myocardial infarction	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1789	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	12238111000119106	Acute ST segment elevation myocardial infarction of inferolateral wall	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1790	ALTEPLASE	Myocardial infarction	TA052	myocardial infarction	16837681000119104	Myocardial infarction due to demand ischaemia	ALTEPLASE	CARDIOLOGY	CARDIOLOGY
1791	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	6142004	Influenza	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1792	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	24662006	Influenza caused by Influenza B virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1793	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	41269000	Influenzal bronchopneumonia	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1794	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	44470000	Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1795	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	46233009	Influenza virus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1796	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	51593004	Haemophilus parainfluenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1797	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	64917006	Pneumonia due to parainfluenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1798	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	70036007	Haemophilus influenzae pneumonia	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1799	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	74644004	Influenza with encephalopathy	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1800	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	86198006	Administration of vaccine product containing only Influenza virus antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1801	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	89117003	Parainfluenza virus type 4	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1802	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	91428005	Haemophilus influenzae infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1803	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	95891005	Influenza-like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1804	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	120753009	Influenza A virus antibody	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1805	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	120843002	Influenza B virus Ab	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1806	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	120975003	Haemophilus influenzae type b antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1807	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	127787002	Haemophilus influenzae type b immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1808	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170343007	First Haemophilus influenzae type b vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1809	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170344001	Administration of second dose of Haemophilus influenzae type b vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1810	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170345000	Third Haemophilus influenzae type b vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1811	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170346004	Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1812	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170428009	First Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1813	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170429001	Second Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1814	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	170430006	Third Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1815	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	171272004	No consent - influenza immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1816	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	171282003	Influenza immunization advised at home	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1817	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	171290003	Influenza vaccination consent given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1818	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	171291004	No consent for Haemophilus influenzae type b immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1819	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	185900003	Has influenza vaccination at home	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1820	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	185901004	Has influenza vaccination at surgery	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1821	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	185902006	Has influenza vaccination at hospital	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1822	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	185903001	Needs influenza immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1823	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	192721000	Post influenza vaccination encephalitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1824	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	194946005	Acute myocarditis - influenzal	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1825	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195721005	Acute bronchitis caused by Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1826	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195726000	Acute parainfluenza virus bronchitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1827	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195878008	Pneumonia and influenza	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1828	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195923003	Influenza with laryngitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1829	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195924009	Influenza with pharyngitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1830	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195929004	Influenza with gastrointestinal tract involvement	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1831	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	195931008	Influenza like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1832	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	234558001	Anti-Haemophilus influenzae type b capsular polysaccharide antibody deficiency	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1833	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	266393000	Influenza-like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1834	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	268561003	Influenza immunization advised in surgery	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1835	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	275983007	Influenza immunisation advised	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1836	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	291749008	Influenza vaccine poisoning	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1837	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	293112000	Influenza split virion vaccine adverse reaction	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1838	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	293113005	Influenza surface antigen vaccine adverse reaction	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1839	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	293127000	Adverse reaction to Haemophilus influenzae type b vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1840	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	294647003	Allergy to influenza vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1841	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	294648008	Allergy to influenza split virion vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1842	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	294649000	Allergy to influenza surface antigen vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1843	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	294664000	Haemophilus influenzae type b vaccine allergy	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1844	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	308532005	Influenza vaccination status	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1845	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	309789002	Encephalitis caused by Influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1846	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	310306005	First diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1847	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	310307001	Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1848	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	310308006	Administration of third dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1849	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	312870000	Diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1850	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	313383003	Fourth diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1851	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	315640000	Influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1852	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	315641001	Influenza vaccination invitation letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1853	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	390796006	Influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1854	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	396425006	FLU - Influenza vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1855	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407479009	Influenza A virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1856	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407480007	Influenza B virus(B/Lee/40)	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1857	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407489008	Human parainfluenza virus 1	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1858	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407491000	Parainfluenza virus type 2	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1859	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407493002	Human parainfluenza virus 3	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1860	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407498006	Human parainfluenza viruses	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1861	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407573008	Influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1862	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	407598009	No consent for third Haemophilus influenzae type b vaccine booster	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1863	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	413103005	Did not attend diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1864	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	413105003	Did not attend second diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1865	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	413106002	Did not attend third diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1866	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	414001002	Diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1867	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	414259000	First diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1868	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	414496007	Influenza vaccination telephone invite	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1869	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	415507003	Second diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1870	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	415712004	Administration of third dose of diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1871	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	416928007	Has influenza vaccination at work	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1872	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	420113004	Adverse reaction to component of vaccine product containing Influenza virus antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1873	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	428975001	Haemophilus influenzae type b and meningitis C immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1874	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	441043003	Influenza A virus subtype H1 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1875	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	441049004	Influenza A virus subtype H3 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1876	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	441343005	Influenza A virus subtype H5 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1877	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	441344004	Human parainfluenza virus present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1878	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	441345003	Influenza B virus present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1879	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	442438000	Influenza caused by Influenza A virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1880	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	442696006	Influenza A (H1N1) swine flu	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1881	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	444426005	Swine influenza contact	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1882	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	447685007	Severe sepsis with acute organ dysfunction caused by Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1883	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	473169009	History of influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1884	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	698353005	Requires influenza virus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1885	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	698950001	Influenza A virus subtype H1N1 vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1886	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	709410003	Hib (Haemophilus influenzae type b) infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1887	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	711330007	Influenza A virus subtype H1N1 detected	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1888	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	711334003	Influenza A virus H1N1 subtype not detected	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1889	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	712833000	Second Haemophilus influenzae type b and meningitis C vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1890	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	712834006	First Haemophilus influenzae type b and meningitis C immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1891	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	719886001	Haemophilus influenzae type b vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1892	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	736818002	Influenza vaccination requested	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1893	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	737041000	Influenza immunisation telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1894	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	770608009	Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1895	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	770616000	First diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1896	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	770617009	Second diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1897	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	770618004	Administration of third dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1898	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	787016008	Administration of influenza vaccine via nasal route	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1899	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1162640003	Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1900	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	61811000000102	Hib (haemophilus influenzae type B) and meningitis C vaccination not done	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1901	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	63281000000106	First intranasal seasonal influenza vaccination not done	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1902	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	73701000119109	Vaccination for influenza given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1903	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	88381000000109	No consent for 2nd HIB (haemophilus influenzae type B) booster	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1904	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	135221000119101	Influenza A H1N1 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1905	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	166311000000109	Influenza immunisation for those in the 65 years and over and other at risk groups enhanced services administration	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1906	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	199331000000106	Did not attend influenza vaccination appointment	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1907	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	200481000000107	Influenza vaccination invitation first letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1908	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	200491000000109	Influenza vaccination invitation second letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1909	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	200501000000103	Influenza vaccination invitation third letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1910	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	201391000000106	Booster influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1911	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	202301000000106	First pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1912	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	202311000000108	Second pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1913	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	299161000000100	Hib/MenC (Haemophilus influenzae type B and meningitis C) vaccination refused	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1914	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	310551000000106	Booster diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1915	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	335051000000104	Booster diphtheria, tetanus, acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1916	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	379241000000107	Booster diphtheria tetanus and three component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1917	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380271000000101	Consent given for pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1918	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380381000000108	Pandemic influenza vaccination refused	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1919	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380631000000100	Pandemic influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1920	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380741000000101	First pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1921	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380771000000107	Second pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1922	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	380801000000105	Pandemic influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1923	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	505251000000100	Suspected influenza A virus subtype H1N1 infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1924	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	506751000000104	Possible influenza A virus H1N1 subtype	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1925	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	506901000000103	Close contact with Influenza A virus subtype H1N1	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1926	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	511571000000106	Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, haemophilus influenzae type b vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1927	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	511781000000101	Advice given about Influenza A virus subtype H1N1 infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1928	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515281000000108	PANDEMRIX - first influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1929	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515291000000105	CELVAPAN - first influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1930	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515301000000109	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1931	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515321000000100	CELVAPAN - second influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1932	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515331000000103	CELVAPAN - first influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1933	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515341000000107	PANDEMRIX - first influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1934	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515351000000105	CELVAPAN - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1935	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515361000000108	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1936	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	515371000000101	No consent for influenza A (H1N1v) 2009 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1937	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	516101000000103	No response to influenza vaccination invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1938	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	518961000000102	Consent given for influenza A subtype H1N1 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1939	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	519421000000105	Did not attend Hib (haemophilus influenzae type B) and meningitis C vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1940	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	540151000000108	Pneumonia or influenza NOS	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1941	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	711301000000108	Influenza vaccination invitation SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1942	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	711831000000107	High priority for influenza A subtype H1N1 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1943	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	761311000000109	Influenza vaccination verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1944	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	764141000000106	Second Haemophilus influenzae type B and Neisseria meningitidis serotype C combination vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1945	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	774801000000105	Influenza A virus subtype H1N1 vaccination invitation short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1946	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	777791000000102	Influenza vaccination invitation first text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1947	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	777831000000109	Influenza vaccination invitation second short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1948	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	777851000000102	Influenza vaccination invitation third SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1949	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	822851000000102	Seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1950	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	822931000000100	Seasonal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1951	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	822951000000107	Seasonal influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1952	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	822971000000103	Seasonal influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1953	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	822991000000104	Consent given for seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1954	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	844941000000103	Influenza vaccination invitation email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1955	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	844961000000102	Influenza vaccination invitation first email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1956	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	844981000000106	Influenza vaccination invitation second email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1957	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	845001000000101	Influenza vaccination invitation third email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1958	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	860151000000103	Influenza vaccination first verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1959	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	860171000000107	Influenza vaccination second verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1960	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	860211000000105	Influenza vaccination second telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1961	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	860291000000101	Influenza vaccination third verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1962	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	868241000000109	Administration of intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1963	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	868491000000103	No consent for seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1964	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	871521000000104	First intranasal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1965	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	871541000000106	Second intranasal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1966	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	871751000000104	Administration of first intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1967	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	871781000000105	Administration of second intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1968	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	873681000000101	Provision of information about seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1969	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	882141000000100	Did not attend second intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1970	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	882181000000108	Did not attend first intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1971	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884821000000108	Administration of first intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1972	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884841000000101	Administration of second intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1973	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884861000000100	Administration of first intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1974	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884881000000109	Administration of second intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1975	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884901000000107	First intranasal pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1976	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	884921000000103	Second intranasal pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1977	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	885971000000103	First intranasal seasonal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1978	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	885991000000104	First intranasal pandemic influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1979	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	886011000000103	Second intranasal seasonal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1980	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	886071000000108	Did not attend first intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1981	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	886111000000102	Did not attend second intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1982	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	897331000000109	Hib (haemophilus influenzae type b) and meningitis C vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1983	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	898291000000101	DTaP/IPV/Hib (Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b) vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1984	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	913961000000102	Education about influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1985	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	932221000000103	At risk of influenza related complication	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1986	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	935351000000106	Long term indication for seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1987	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	945831000000105	First intramuscular seasonal influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1988	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955641000000103	Influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1989	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955651000000100	Seasonal influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1990	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955661000000102	First intranasal seasonal influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1991	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955671000000109	Second intramuscular seasonal influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1992	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955681000000106	Second intranasal seasonal influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1993	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955691000000108	Seasonal influenza vaccination given by pharmacist	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1994	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	955701000000108	Seasonal influenza vaccination given while hospital inpatient	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1995	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	985151000000100	Administration of first inactivated seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1996	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	985171000000109	Administration of second inactivated seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1997	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	996211000000100	Influenza (A and B) serology	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1998	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	996761000000106	Haemophilus influenzae B IgG level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
1999	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1001341000000106	Influenza A antigen level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2000	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1001351000000109	Influenza B antigen level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2001	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1005101000000108	Parainfluenza virus antibody level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2002	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1005111000000105	Parainfluenza type 3 antibody level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2003	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008161000000101	Parainfluenza virus type 3 RNA (ribonucleic acid detection) assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2004	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008171000000108	Parainfluenza virus type 2 RNA (ribonucleic acid) detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2005	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008181000000105	Parainfluenza virus type 1 RNA (ribonucleic acid) detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2006	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008251000000105	Influenza B virus ribonucleic acid detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2007	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008261000000108	Influenza A virus ribonucleic acid detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2008	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1008771000000107	Haemophilus influenzae B antibody level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2009	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1010721000000107	Avian influenza virus RNA (ribonucleic acid) detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2010	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1014261000000103	Influenza A antibody level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2011	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1014271000000105	Influenza B antibody level	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2012	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1020381000000100	Parainfluenza virus antigen assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2013	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1029731000000105	Parainfluenza type 1 nucleic acid detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2014	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1031631000000102	Avian influenza virus nucleic acid detection assay	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2015	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1033051000000101	Influenza due to zoonotic influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2016	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1033071000000105	Influenza due to pandemic influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2017	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1033091000000109	Influenza due to seasonal influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2018	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1033111000000104	Influenza with pneumonia due to seasonal influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2019	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1037311000000106	First intranasal seasonal influenza vaccination given by pharmacist	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2020	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1037331000000103	Second intranasal seasonal influenza vaccination given by pharmacist	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2021	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1037351000000105	First inactivated seasonal influenza vaccination given by pharmacist	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2022	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1037371000000101	Second inactivated seasonal influenza vaccination given by pharmacist	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2023	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1066171000000108	Seasonal influenza vaccination given by midwife	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2024	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1066181000000105	First inactivated seasonal influenza vaccination given by midwife	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2025	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1066191000000107	Second inactivated seasonal influenza vaccination given by midwife	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2026	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1082431000000104	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2027	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1082441000000108	First diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2028	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1082451000000106	Second diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2029	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1082461000000109	Third diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2030	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1082521000000100	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2031	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1083421000000107	Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2032	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1086431000000100	First diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2033	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1086441000000109	Second diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2034	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1086451000000107	Third diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2035	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1095821000000105	Influenza vaccination first telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2036	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1095831000000107	Influenza vaccination second telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2037	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1095841000000103	Influenza vaccination third telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2038	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1239861000000100	Seasonal influenza vaccination given in school	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2039	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1484821000000104	Influenza vaccination invitation short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2040	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1484831000000102	Influenza vaccination invitation first SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2041	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1484841000000106	Influenza vaccination invitation second SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2042	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	1484851000000109	Influenza vaccination invitation third short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2043	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	2427211000000109	Fourth diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2044	AMANTADINE	Influenza (post-exposure prophylaxis)	TA158	influenza	3244411000001106	Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (Sanofi Pasteur)	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2045	AMANTADINE	Influenza (prevention)	TA067	influenza	6142004	Influenza	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2046	AMANTADINE	Influenza (prevention)	TA067	influenza	24662006	Influenza caused by Influenza B virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2047	AMANTADINE	Influenza (prevention)	TA067	influenza	41269000	Influenzal bronchopneumonia	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2048	AMANTADINE	Influenza (prevention)	TA067	influenza	44470000	Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2049	AMANTADINE	Influenza (prevention)	TA067	influenza	46233009	Influenza virus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2050	AMANTADINE	Influenza (prevention)	TA067	influenza	51593004	Haemophilus parainfluenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2051	AMANTADINE	Influenza (prevention)	TA067	influenza	64917006	Pneumonia due to parainfluenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2052	AMANTADINE	Influenza (prevention)	TA067	influenza	70036007	Haemophilus influenzae pneumonia	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2053	AMANTADINE	Influenza (prevention)	TA067	influenza	74644004	Influenza with encephalopathy	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2054	AMANTADINE	Influenza (prevention)	TA067	influenza	86198006	Administration of vaccine product containing only Influenza virus antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2055	AMANTADINE	Influenza (prevention)	TA067	influenza	89117003	Parainfluenza virus type 4	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2056	AMANTADINE	Influenza (prevention)	TA067	influenza	91428005	Haemophilus influenzae infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2057	AMANTADINE	Influenza (prevention)	TA067	influenza	95891005	Influenza-like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2058	AMANTADINE	Influenza (prevention)	TA067	influenza	120753009	Influenza A virus antibody	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2059	AMANTADINE	Influenza (prevention)	TA067	influenza	120843002	Influenza B virus Ab	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2060	AMANTADINE	Influenza (prevention)	TA067	influenza	120975003	Haemophilus influenzae type b antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2061	AMANTADINE	Influenza (prevention)	TA067	influenza	127787002	Haemophilus influenzae type b immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2062	AMANTADINE	Influenza (prevention)	TA067	influenza	170343007	First Haemophilus influenzae type b vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2063	AMANTADINE	Influenza (prevention)	TA067	influenza	170344001	Administration of second dose of Haemophilus influenzae type b vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2064	AMANTADINE	Influenza (prevention)	TA067	influenza	170345000	Third Haemophilus influenzae type b vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2065	AMANTADINE	Influenza (prevention)	TA067	influenza	170346004	Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2066	AMANTADINE	Influenza (prevention)	TA067	influenza	170428009	First Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2067	AMANTADINE	Influenza (prevention)	TA067	influenza	170429001	Second Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2068	AMANTADINE	Influenza (prevention)	TA067	influenza	170430006	Third Haemophilus influenzae type b and diphtheria, tetanus and pertussis vaccine given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2069	AMANTADINE	Influenza (prevention)	TA067	influenza	171272004	No consent - influenza immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2070	AMANTADINE	Influenza (prevention)	TA067	influenza	171282003	Influenza immunization advised at home	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2071	AMANTADINE	Influenza (prevention)	TA067	influenza	171290003	Influenza vaccination consent given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2072	AMANTADINE	Influenza (prevention)	TA067	influenza	171291004	No consent for Haemophilus influenzae type b immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2073	AMANTADINE	Influenza (prevention)	TA067	influenza	185900003	Has influenza vaccination at home	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2074	AMANTADINE	Influenza (prevention)	TA067	influenza	185901004	Has influenza vaccination at surgery	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2075	AMANTADINE	Influenza (prevention)	TA067	influenza	185902006	Has influenza vaccination at hospital	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2076	AMANTADINE	Influenza (prevention)	TA067	influenza	185903001	Needs influenza immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2077	AMANTADINE	Influenza (prevention)	TA067	influenza	192721000	Post influenza vaccination encephalitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2078	AMANTADINE	Influenza (prevention)	TA067	influenza	194946005	Acute myocarditis - influenzal	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2079	AMANTADINE	Influenza (prevention)	TA067	influenza	195721005	Acute bronchitis caused by Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2080	AMANTADINE	Influenza (prevention)	TA067	influenza	195726000	Acute parainfluenza virus bronchitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2081	AMANTADINE	Influenza (prevention)	TA067	influenza	195878008	Pneumonia and influenza	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2082	AMANTADINE	Influenza (prevention)	TA067	influenza	195923003	Influenza with laryngitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2083	AMANTADINE	Influenza (prevention)	TA067	influenza	195924009	Influenza with pharyngitis	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2084	AMANTADINE	Influenza (prevention)	TA067	influenza	195929004	Influenza with gastrointestinal tract involvement	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2085	AMANTADINE	Influenza (prevention)	TA067	influenza	195931008	Influenza like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2086	AMANTADINE	Influenza (prevention)	TA067	influenza	234558001	Anti-Haemophilus influenzae type b capsular polysaccharide antibody deficiency	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2087	AMANTADINE	Influenza (prevention)	TA067	influenza	266393000	Influenza-like illness	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2088	AMANTADINE	Influenza (prevention)	TA067	influenza	268561003	Influenza immunization advised in surgery	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2089	AMANTADINE	Influenza (prevention)	TA067	influenza	275983007	Influenza immunisation advised	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2090	AMANTADINE	Influenza (prevention)	TA067	influenza	291749008	Influenza vaccine poisoning	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2091	AMANTADINE	Influenza (prevention)	TA067	influenza	293112000	Influenza split virion vaccine adverse reaction	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2092	AMANTADINE	Influenza (prevention)	TA067	influenza	293113005	Influenza surface antigen vaccine adverse reaction	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2093	AMANTADINE	Influenza (prevention)	TA067	influenza	293127000	Adverse reaction to Haemophilus influenzae type b vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2094	AMANTADINE	Influenza (prevention)	TA067	influenza	294647003	Allergy to influenza vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2095	AMANTADINE	Influenza (prevention)	TA067	influenza	294648008	Allergy to influenza split virion vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2096	AMANTADINE	Influenza (prevention)	TA067	influenza	294649000	Allergy to influenza surface antigen vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2097	AMANTADINE	Influenza (prevention)	TA067	influenza	294664000	Haemophilus influenzae type b vaccine allergy	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2098	AMANTADINE	Influenza (prevention)	TA067	influenza	308532005	Influenza vaccination status	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2099	AMANTADINE	Influenza (prevention)	TA067	influenza	309789002	Encephalitis caused by Influenza virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2100	AMANTADINE	Influenza (prevention)	TA067	influenza	310306005	First diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2101	AMANTADINE	Influenza (prevention)	TA067	influenza	310307001	Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2102	AMANTADINE	Influenza (prevention)	TA067	influenza	310308006	Administration of third dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2103	AMANTADINE	Influenza (prevention)	TA067	influenza	312870000	Diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2104	AMANTADINE	Influenza (prevention)	TA067	influenza	313383003	Fourth diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2105	AMANTADINE	Influenza (prevention)	TA067	influenza	315640000	Influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2106	AMANTADINE	Influenza (prevention)	TA067	influenza	315641001	Influenza vaccination invitation letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2107	AMANTADINE	Influenza (prevention)	TA067	influenza	390796006	Influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2108	AMANTADINE	Influenza (prevention)	TA067	influenza	396425006	FLU - Influenza vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2109	AMANTADINE	Influenza (prevention)	TA067	influenza	407479009	Influenza A virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2110	AMANTADINE	Influenza (prevention)	TA067	influenza	407480007	Influenza B virus(B/Lee/40)	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2111	AMANTADINE	Influenza (prevention)	TA067	influenza	407489008	Human parainfluenza virus 1	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2112	AMANTADINE	Influenza (prevention)	TA067	influenza	407491000	Parainfluenza virus type 2	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2113	AMANTADINE	Influenza (prevention)	TA067	influenza	407493002	Human parainfluenza virus 3	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2114	AMANTADINE	Influenza (prevention)	TA067	influenza	407498006	Human parainfluenza viruses	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2115	AMANTADINE	Influenza (prevention)	TA067	influenza	407573008	Influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2116	AMANTADINE	Influenza (prevention)	TA067	influenza	407598009	No consent for third Haemophilus influenzae type b vaccine booster	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2117	AMANTADINE	Influenza (prevention)	TA067	influenza	413103005	Did not attend diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2118	AMANTADINE	Influenza (prevention)	TA067	influenza	413105003	Did not attend second diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2119	AMANTADINE	Influenza (prevention)	TA067	influenza	413106002	Did not attend third diphtheria, tetanus and pertussis, Haemophilus influenzae type b and polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2120	AMANTADINE	Influenza (prevention)	TA067	influenza	414001002	Diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2121	AMANTADINE	Influenza (prevention)	TA067	influenza	414259000	First diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2122	AMANTADINE	Influenza (prevention)	TA067	influenza	414496007	Influenza vaccination telephone invite	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2123	AMANTADINE	Influenza (prevention)	TA067	influenza	415507003	Second diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2124	AMANTADINE	Influenza (prevention)	TA067	influenza	415712004	Administration of third dose of diphtheria and Haemophilus influenza type b and five component acellular pertussis and inactivated poliomyelitis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2125	AMANTADINE	Influenza (prevention)	TA067	influenza	416928007	Has influenza vaccination at work	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2126	AMANTADINE	Influenza (prevention)	TA067	influenza	420113004	Adverse reaction to component of vaccine product containing Influenza virus antigen	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2127	AMANTADINE	Influenza (prevention)	TA067	influenza	428975001	Haemophilus influenzae type b and meningitis C immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2128	AMANTADINE	Influenza (prevention)	TA067	influenza	441043003	Influenza A virus subtype H1 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2129	AMANTADINE	Influenza (prevention)	TA067	influenza	441049004	Influenza A virus subtype H3 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2130	AMANTADINE	Influenza (prevention)	TA067	influenza	441343005	Influenza A virus subtype H5 present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2131	AMANTADINE	Influenza (prevention)	TA067	influenza	441344004	Human parainfluenza virus present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2132	AMANTADINE	Influenza (prevention)	TA067	influenza	441345003	Influenza B virus present	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2133	AMANTADINE	Influenza (prevention)	TA067	influenza	442438000	Influenza caused by Influenza A virus	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2134	AMANTADINE	Influenza (prevention)	TA067	influenza	442696006	Influenza A (H1N1) swine flu	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2135	AMANTADINE	Influenza (prevention)	TA067	influenza	444426005	Swine influenza contact	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2136	AMANTADINE	Influenza (prevention)	TA067	influenza	447685007	Severe sepsis with acute organ dysfunction caused by Haemophilus influenzae	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2137	AMANTADINE	Influenza (prevention)	TA067	influenza	473169009	History of influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2138	AMANTADINE	Influenza (prevention)	TA067	influenza	698353005	Requires influenza virus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2139	AMANTADINE	Influenza (prevention)	TA067	influenza	698950001	Influenza A virus subtype H1N1 vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2140	AMANTADINE	Influenza (prevention)	TA067	influenza	709410003	Hib (Haemophilus influenzae type b) infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2141	AMANTADINE	Influenza (prevention)	TA067	influenza	711330007	Influenza A virus subtype H1N1 detected	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2142	AMANTADINE	Influenza (prevention)	TA067	influenza	711334003	Influenza A virus H1N1 subtype not detected	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2143	AMANTADINE	Influenza (prevention)	TA067	influenza	712833000	Second Haemophilus influenzae type b and meningitis C vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2144	AMANTADINE	Influenza (prevention)	TA067	influenza	712834006	First Haemophilus influenzae type b and meningitis C immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2145	AMANTADINE	Influenza (prevention)	TA067	influenza	719886001	Haemophilus influenzae type b vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2146	AMANTADINE	Influenza (prevention)	TA067	influenza	736818002	Influenza vaccination requested	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2147	AMANTADINE	Influenza (prevention)	TA067	influenza	737041000	Influenza immunisation telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2148	AMANTADINE	Influenza (prevention)	TA067	influenza	770608009	Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2149	AMANTADINE	Influenza (prevention)	TA067	influenza	770616000	First diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunisation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2150	AMANTADINE	Influenza (prevention)	TA067	influenza	770617009	Second diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus immunization	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2151	AMANTADINE	Influenza (prevention)	TA067	influenza	770618004	Administration of third dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2152	AMANTADINE	Influenza (prevention)	TA067	influenza	787016008	Administration of influenza vaccine via nasal route	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2153	AMANTADINE	Influenza (prevention)	TA067	influenza	1162640003	Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2154	AMANTADINE	Influenza (prevention)	TA067	influenza	61811000000102	Hib (haemophilus influenzae type B) and meningitis C vaccination not done	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2155	AMANTADINE	Influenza (prevention)	TA067	influenza	63281000000106	First intranasal seasonal influenza vaccination not done	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2156	AMANTADINE	Influenza (prevention)	TA067	influenza	73701000119109	Vaccination for influenza given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2157	AMANTADINE	Influenza (prevention)	TA067	influenza	88381000000109	No consent for 2nd HIB (haemophilus influenzae type B) booster	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2158	AMANTADINE	Influenza (prevention)	TA067	influenza	135221000119101	Influenza A H1N1 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2159	AMANTADINE	Influenza (prevention)	TA067	influenza	166311000000109	Influenza immunisation for those in the 65 years and over and other at risk groups enhanced services administration	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2160	AMANTADINE	Influenza (prevention)	TA067	influenza	199331000000106	Did not attend influenza vaccination appointment	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2161	AMANTADINE	Influenza (prevention)	TA067	influenza	200481000000107	Influenza vaccination invitation first letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2162	AMANTADINE	Influenza (prevention)	TA067	influenza	200491000000109	Influenza vaccination invitation second letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2163	AMANTADINE	Influenza (prevention)	TA067	influenza	200501000000103	Influenza vaccination invitation third letter sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2164	AMANTADINE	Influenza (prevention)	TA067	influenza	201391000000106	Booster influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2165	AMANTADINE	Influenza (prevention)	TA067	influenza	202301000000106	First pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2166	AMANTADINE	Influenza (prevention)	TA067	influenza	202311000000108	Second pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2167	AMANTADINE	Influenza (prevention)	TA067	influenza	299161000000100	Hib/MenC (Haemophilus influenzae type B and meningitis C) vaccination refused	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2168	AMANTADINE	Influenza (prevention)	TA067	influenza	310551000000106	Booster diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2169	AMANTADINE	Influenza (prevention)	TA067	influenza	335051000000104	Booster diphtheria, tetanus, acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2170	AMANTADINE	Influenza (prevention)	TA067	influenza	379241000000107	Booster diphtheria tetanus and three component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2171	AMANTADINE	Influenza (prevention)	TA067	influenza	380271000000101	Consent given for pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2172	AMANTADINE	Influenza (prevention)	TA067	influenza	380381000000108	Pandemic influenza vaccination refused	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2173	AMANTADINE	Influenza (prevention)	TA067	influenza	380631000000100	Pandemic influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2174	AMANTADINE	Influenza (prevention)	TA067	influenza	380741000000101	First pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2175	AMANTADINE	Influenza (prevention)	TA067	influenza	380771000000107	Second pandemic influenza vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2176	AMANTADINE	Influenza (prevention)	TA067	influenza	380801000000105	Pandemic influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2177	AMANTADINE	Influenza (prevention)	TA067	influenza	505251000000100	Suspected influenza A virus subtype H1N1 infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2178	AMANTADINE	Influenza (prevention)	TA067	influenza	506751000000104	Possible influenza A virus H1N1 subtype	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2179	AMANTADINE	Influenza (prevention)	TA067	influenza	506901000000103	Close contact with Influenza A virus subtype H1N1	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2180	AMANTADINE	Influenza (prevention)	TA067	influenza	511571000000106	Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, haemophilus influenzae type b vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2181	AMANTADINE	Influenza (prevention)	TA067	influenza	511781000000101	Advice given about Influenza A virus subtype H1N1 infection	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2182	AMANTADINE	Influenza (prevention)	TA067	influenza	515281000000108	PANDEMRIX - first influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2183	AMANTADINE	Influenza (prevention)	TA067	influenza	515291000000105	CELVAPAN - first influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2184	AMANTADINE	Influenza (prevention)	TA067	influenza	515301000000109	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2185	AMANTADINE	Influenza (prevention)	TA067	influenza	515321000000100	CELVAPAN - second influenza A (H1N1v) 2009 vaccination given	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2186	AMANTADINE	Influenza (prevention)	TA067	influenza	515331000000103	CELVAPAN - first influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2187	AMANTADINE	Influenza (prevention)	TA067	influenza	515341000000107	PANDEMRIX - first influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2188	AMANTADINE	Influenza (prevention)	TA067	influenza	515351000000105	CELVAPAN - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2189	AMANTADINE	Influenza (prevention)	TA067	influenza	515361000000108	PANDEMRIX - second influenza A (H1N1v) 2009 vaccination given by other healthcare provider	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2190	AMANTADINE	Influenza (prevention)	TA067	influenza	515371000000101	No consent for influenza A (H1N1v) 2009 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2191	AMANTADINE	Influenza (prevention)	TA067	influenza	516101000000103	No response to influenza vaccination invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2192	AMANTADINE	Influenza (prevention)	TA067	influenza	518961000000102	Consent given for influenza A subtype H1N1 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2193	AMANTADINE	Influenza (prevention)	TA067	influenza	519421000000105	Did not attend Hib (haemophilus influenzae type B) and meningitis C vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2194	AMANTADINE	Influenza (prevention)	TA067	influenza	540151000000108	Pneumonia or influenza NOS	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2195	AMANTADINE	Influenza (prevention)	TA067	influenza	711301000000108	Influenza vaccination invitation SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2196	AMANTADINE	Influenza (prevention)	TA067	influenza	711831000000107	High priority for influenza A subtype H1N1 vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2197	AMANTADINE	Influenza (prevention)	TA067	influenza	761311000000109	Influenza vaccination verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2198	AMANTADINE	Influenza (prevention)	TA067	influenza	764141000000106	Second Haemophilus influenzae type B and Neisseria meningitidis serotype C combination vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2199	AMANTADINE	Influenza (prevention)	TA067	influenza	774801000000105	Influenza A virus subtype H1N1 vaccination invitation short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2200	AMANTADINE	Influenza (prevention)	TA067	influenza	777791000000102	Influenza vaccination invitation first text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2201	AMANTADINE	Influenza (prevention)	TA067	influenza	777831000000109	Influenza vaccination invitation second short message service text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2202	AMANTADINE	Influenza (prevention)	TA067	influenza	777851000000102	Influenza vaccination invitation third SMS (short message service) text message sent	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2203	AMANTADINE	Influenza (prevention)	TA067	influenza	822851000000102	Seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2204	AMANTADINE	Influenza (prevention)	TA067	influenza	822931000000100	Seasonal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2205	AMANTADINE	Influenza (prevention)	TA067	influenza	822951000000107	Seasonal influenza vaccination contraindicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2206	AMANTADINE	Influenza (prevention)	TA067	influenza	822971000000103	Seasonal influenza vaccination not indicated	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2207	AMANTADINE	Influenza (prevention)	TA067	influenza	822991000000104	Consent given for seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2208	AMANTADINE	Influenza (prevention)	TA067	influenza	844941000000103	Influenza vaccination invitation email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2209	AMANTADINE	Influenza (prevention)	TA067	influenza	844961000000102	Influenza vaccination invitation first email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2210	AMANTADINE	Influenza (prevention)	TA067	influenza	844981000000106	Influenza vaccination invitation second email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2211	AMANTADINE	Influenza (prevention)	TA067	influenza	845001000000101	Influenza vaccination invitation third email	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2212	AMANTADINE	Influenza (prevention)	TA067	influenza	860151000000103	Influenza vaccination first verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2213	AMANTADINE	Influenza (prevention)	TA067	influenza	860171000000107	Influenza vaccination second verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2214	AMANTADINE	Influenza (prevention)	TA067	influenza	860211000000105	Influenza vaccination second telephone invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2215	AMANTADINE	Influenza (prevention)	TA067	influenza	860291000000101	Influenza vaccination third verbal invitation	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2216	AMANTADINE	Influenza (prevention)	TA067	influenza	868241000000109	Administration of intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2217	AMANTADINE	Influenza (prevention)	TA067	influenza	868491000000103	No consent for seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2218	AMANTADINE	Influenza (prevention)	TA067	influenza	871521000000104	First intranasal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2219	AMANTADINE	Influenza (prevention)	TA067	influenza	871541000000106	Second intranasal influenza vaccination declined	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2220	AMANTADINE	Influenza (prevention)	TA067	influenza	871751000000104	Administration of first intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2221	AMANTADINE	Influenza (prevention)	TA067	influenza	871781000000105	Administration of second intranasal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2222	AMANTADINE	Influenza (prevention)	TA067	influenza	873681000000101	Provision of information about seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2223	AMANTADINE	Influenza (prevention)	TA067	influenza	882141000000100	Did not attend second intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2224	AMANTADINE	Influenza (prevention)	TA067	influenza	882181000000108	Did not attend first intranasal seasonal influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2225	AMANTADINE	Influenza (prevention)	TA067	influenza	884821000000108	Administration of first intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEASES\|GENERAL MEDICINE
2226	AMANTADINE	Influenza (prevention)	TA067	influenza	884841000000101	Administration of second intranasal pandemic influenza vaccination	AMANTADINE	INFECTIOUS DISEASES	INFECTIOUS DISEAS

The file is too large to be shown. View Raw

7.8 MiB Raw Blame History

7.8 MiB

Raw Blame History